<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">Drug Deliv</span><span class="iso-abbrev" title="iso-abbrev">Drug Deliv</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">Drug Delivery</span></div><span class="issn-ppub" tagx="issn" title="issn-ppub">1071-7544</span><span class="issn-epub" tagx="issn" title="issn-epub">1521-0464</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">Taylor &amp;amp; Francis</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/7751395">7751395</a></span><span class="pmid" title="pmid"> pmid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/33336610">33336610</a></span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1080/10717544.2020.1856225">10.1080/10717544.2020.1856225</a></span><span class="publisher-id" title="publisher-id">1856225</span><div class="unknown" title="article-version" tag="article-version">
Version of Record</div> <div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Research Article</span>: <span class="subject" title="subject">Research Article</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title">
The optimized drug delivery systems of treating cancer bone metastatic osteolysis with nanomaterials</div> <div class="alt-title" title="alt-title">
X. Cheng et al.</div> </div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0002-7143-0388</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cheng</span><span class="given-names" tagx="given-names" title="given-names">Xi</span></span><a href="#AF0001">a</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wei</span><span class="given-names" tagx="given-names" title="given-names">Jinrong</span></span><a href="#AF0001">a</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ge</span><span class="given-names" tagx="given-names" title="given-names">Qi</span></span><a href="#AF0001">a</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xing</span><span class="given-names" tagx="given-names" title="given-names">Danlei</span></span><a href="#AF0001">a</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">Xuefeng</span></span><a href="#AF0002">b</a><a href="#AN0003" /></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Qian</span><span class="given-names" tagx="given-names" title="given-names">Yunzhu</span></span><a href="#AF0003">c</a><a href="#AN0002" /></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jiang</span><span class="given-names" tagx="given-names" title="given-names">Guoqin</span></span><a href="#AF0001">a</a><a href="#AN0001" /></span><span class="citation_author_institution" id="AF0001">[a], <span class="institution" title="institution">Department of Surgery, The Second Affiliated Hospital of Soochow University</span><span class="city" tagx="city" title="city">Suzhou</span><span class="country" tagx="country" title="country">Peopleâ€™s Republic of China</span></span><span class="citation_author_institution" id="AF0002">[b], <span class="institution" title="institution">State Key Laboratory of Bioelectronics, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University</span><span class="city" tagx="city" title="city">Nanjing</span><span class="country" tagx="country" title="country">Peopleâ€™s Republic of China</span></span><span class="citation_author_institution" id="AF0003">[c], <span class="institution" title="institution">Center of Stomatology, The Second Affiliated Hospital of Soochow University</span><span class="city" tagx="city" title="city">Suzhou</span><span class="country" tagx="country" title="country">Peopleâ€™s Republic of China</span></span></div> <div class="author-notes" title="author-notes"> <div class="corresp" title="corresp"><b>CONTACT</b> Guoqin Jiang <span class="email" tagx="email" title="email">jiang_guoqin@suda.edu.cn</span><span class="institution" title="institution">Department of Surgery, The Second Affiliated Hospital of Soochow University</span>, <span class="addr-line" title="addr-line">No 1055, San-Xiang Road</span>, <span class="city" tagx="city" title="city">Suzhou</span><span class="postal-code" tagx="postal-code" title="postal-code">215004</span>, <span class="country" tagx="country" title="country">Peopleâ€™s Republic of China</span></div> <div class="corresp" title="corresp">
Yunzhu Qian <span class="email" tagx="email" title="email">yunzhu_qian@sina.com</span><span class="institution" title="institution">Center of Stomatology, The Second Affiliated Hospital of Soochow University</span>, <span class="addr-line" title="addr-line">No. 1055, Sanxiang Road</span>, <span class="city" tagx="city" title="city">Suzhou</span><span class="postal-code" tagx="postal-code" title="postal-code">215004</span>, <span class="country" tagx="country" title="country">Peopleâ€™s Republic of China</span></div> <div class="corresp" title="corresp">
Xuefeng Zhou <span class="email" tagx="email" title="email">zhouxuefeng@seu.edu.cn</span><span class="institution" title="institution">State Key Laboratory of Bioelectronics, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University</span>, <span class="addr-line" title="addr-line">No. 2 Sipailou, Xuanwu District</span>, <span class="city" tagx="city" title="city">Nanjing</span><span class="postal-code" tagx="postal-code" title="postal-code">210096</span>, <span class="country" tagx="country" title="country">Peopleâ€™s Republic of China</span></div> </div><span class="pub-date-" title="pub-date-">: <span>2020-12-12</span></span><span class="pub-date-" title="pub-date-">: <span>2021</span></span><span class="volume" tagx="volume" title="volume">28</span><span class="issue" tagx="issue" title="issue">1</span><span class="fpage" tagx="fpage" title="fpage">37</span><span class="lpage" tagx="lpage" title="lpage">53</span><div class="permissions"><span class="copyright" title="copyright">(C) <span class="copyright-holder" tagx="copyright-holder" title="copyright-holder">The Author(s)</span>, <span class="copyright-year" tagx="copyright-year" title="copyright-year">2020</span></span><span class="license" title="license"><span class="license-p" title="license-p">This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<a href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</span></span></div><a class="self-uri" href="IDRD_28_1856225.pdf" title="self-uri">IDRD_28_1856225.pdf</a><div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <div class="title" tagx="title" title="title">
Abstract</div> <p>Some cancers such as human breast cancer, prostate cancer, and lung cancer easily metastasize to bone, leading to osteolysis and bone destruction accompanied by a complicated microenvironment. Systemic administration of bisphosphonates (BP) or denosumab is the routine therapy for osteolysis but with non-negligible side effects such as mandibular osteonecrosis and hypocalcemia. Thus, it is imperative to exploit optimized drug delivery systems, and some novel nanotechnology and nanomaterials have opened new horizons for scientists. Targeted and local drug delivery systems can optimize biodistribution depending on nanoparticles (NPs) or microspheres (MS) and implantable biomaterials with the controllable property. Drug delivery kinetics can be optimized by smart and sustained/local drug delivery systems for responsive delivery and sustained delivery. These delicately fabricated drug delivery systems with special matrix, structure, morphology, and modification can minimize unexpected toxicity caused by systemic delivery and achieve desired effects through integrating multiple drugs or multiple functions. This review summarized recent studies about optimized drug delivery systems for the treatment of cancer metastatic osteolysis, aimed at giving some inspiration in designing efficient multifunctional drug delivery systems.</p> </div> <div class="kwd-group"> <div class="title" tagx="title" title="title">
Keywords</div> <div class="kwd" title="kwd">
Osteolysis</div> <div class="kwd" title="kwd">
cancer bone metastasis</div> <div class="kwd" title="kwd">
drug delivery systems</div> <div class="kwd" title="kwd">
nanomaterials</div> </div> <div class="counts" title="counts"><span class="fig-count" title="fig-count">fig-count: </span><span class="table-count" title="table-count">table-count: </span><span class="page-count" title="page-count">page-count: </span><span class="word-count" title="word-count">word-count: </span></div> </div> </div> <div class="body" title="body"> <div class="introduction" title="sec"><span class="label" tagx="label" title="label">1.</span><div class="title" tagx="title" title="title">
Introduction</div> <p>Bone metastasis and concomitant complications are huge challenges for cancer treatment in the clinic. Bone metastases occur in about 70% of patients suffering from advanced breast cancer or prostate cancer and approximately 15â€"30% of patients with carcinoma of the lung, colon, stomach, bladder, uterus, rectum, thyroid, or kidney (Irelli etÂ al., <a href="#CIT0053">2016</a>; Sun, Han, etÂ al., <a href="#CIT0116">2016</a>). Escaping from the tumor <i>in-situ</i>, tumor cells enter circulation through blood vessels and lymph vessels and then travel all over the body to find fertile soil to proliferate (Croucher etÂ al., <a href="#CIT0023">2016</a>; Vinay &amp;amp; KusumDevi, <a href="#CIT0125">2016</a>; Chen, Pei, etÂ al., <a href="#CIT0017">2018</a>; Ahangar etÂ al., <a href="#CIT0004">2019</a>). The special structure and microenvironment of the bone marrow are beneficial for tumor cells to grow (Ahangar etÂ al., <a href="#CIT0004">2019</a>). Tumor cells replicate in the new environment continually, develop into a metastatic tumor, and destroy the bone structure. Patients with bone metastasis suffer from bone pain, pathological fracture, hypercalcemia, spinal cord compression, and other skeletal-related events (Macedo etÂ al., <a href="#CIT0080">2017</a>; Turpin etÂ al., <a href="#CIT0121">2020</a>). Osteogenic metastasis or osteolytic metastasis both could happen. But osteolytic bone metastases account for approximately 80% of cancer bone metastases (Sun, Ge, etÂ al., <a href="#CIT0115">2019</a>). The â€˜vicious circleâ€™ occurring in the metastasized bone accelerates the cancer cellsâ€™ proliferation and bone destruction at the same time (Santini etÂ al., <a href="#CIT0101">2010</a>; Turpin etÂ al., <a href="#CIT0121">2020</a>). BP and denosumab are common medicine in the clinic but have many side effects. BP may cause mandibular osteonecrosis and impair renal function (Sun, Han, etÂ al., <a href="#CIT0116">2016</a>). Denosumab was reported to increase the risk of pancreatitis and endocarditis, erysipelas, and infectious arthritis (Jie etÂ al., <a href="#CIT0055">2019</a>). Some newly developed drugs have not been used clinically due to their hydrophobicity, short half-life, and other disadvantages (Chew &amp;amp; Danti, <a href="#CIT0020">2017</a>). These undesired effects of systemic drug delivery arise from the uncontrollable â€˜spaceâ€™ and â€˜timeâ€™ of drug reaction. Delightedly, nanotechnology and nanomaterials provide new strategies to build superior drug delivery systems that make drugs more efficient and secure to the body (Chen, Wang, etÂ al., <a href="#CIT0018">2019</a>). Many kinds of NPs were utilized as drug carriers and targeted destroyed bone areas to treat cancer and inhibit bone resorption, such as polymer NPs, liposomes, and silica NPs. Elaborate decorations with targeting ligands endowed particles the ability to target bone or special expression of cancer cells in the osteolytic microenvironment, optimizing the spatial distribution of drugs. The multifunctional implantable scaffolds or hydrogel materials can load a large number of drugs and release drugs locally in a more sustainable way, showing desired efficiency and minimal side effects and reducing the frequency of medication. In addition, smart drug release systems were designed to release drugs in response to some physical and chemical stimuli. Internal chemical characteristics of the osteolytic environment (low pH and high Ca<sup>2+</sup> concentration) and external physical stimuli [near-infrared light (NIR), ultraviolet light, or ultrasound] both can be utilized as triggers of drug release and further optimize the timing of delivery. <a href="#F0001">Figure 1</a> summarized the work of these optimized drug delivery systems.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 1.</span></a></div>   <p>The graphical abstract of the work of optimized drug delivery systems.</p>   </div> </div> <div class="osteolyticcancerbonemetastasis" title="sec"><span class="label" tagx="label" title="label">2.</span><div class="title" tagx="title" title="title">
Osteolytic cancer bone metastasis</div> <p>When metastatic tumor forms, tumor cells interact with normal cells in the vicinity, influence their cellular function, and destroy the primary microenvironment (Futakuchi etÂ al., <a href="#CIT0038">2016</a>; Shupp etÂ al., <a href="#CIT0107">2018</a>). Bone offers metastatic cells unique microenvironments termed â€˜nichesâ€™ (Croucher etÂ al., <a href="#CIT0023">2016</a>; Ahangar etÂ al., <a href="#CIT0004">2019</a>). The slow blood flow in bone, mechanical property, various chemokines, and growth factors are beneficial to tumor cellsâ€™ growth (Zhu etÂ al., <a href="#CIT0153">2018</a>; Turpin etÂ al., <a href="#CIT0121">2020</a>). In the osteolytic microenvironment, the â€˜vicious circleâ€™ between cancer cells, osteoblasts, and osteoclasts facilitates the activation of osteoclasts and suppresses the action of osteoblasts. At the same time, cancer cellsâ€™ proliferation is also promoted continually (Futakuchi etÂ al., <a href="#CIT0038">2016</a>; Saracino etÂ al., <a href="#CIT0103">2016</a>; Turpin etÂ al., <a href="#CIT0121">2020</a>). In brief, metastatic cancer cells produce and excrete parathyroid hormone-related protein (PTHrP), IL-11, TNF-a, and other factors that act on the osteoblasts to promote the expression of receptor activator of nuclear factor-ÎºB (NF-ÎºB) ligand (RANKL). RANKL combines with receptor activator of NF-ÎºB (RANK) on the membrane of preosteoclasts to accelerate osteoclast formation and maturity (Wu etÂ al., <a href="#CIT0138">2020</a>). Cancer cells also express the Notch ligand Jagged1 and VCAM-1 to promote the activation of preosteoclasts (Lu etÂ al., <a href="#CIT0076">2011</a>; Sethi etÂ al., <a href="#CIT0106">2011</a>). The bone matrix contains a variety of growth factors, such as insulin-like growth factors (IGFs), transforming growth factor Î² (TGF-Î²), fibroblast growth factors (FGFs), platelet-derived growth factors (PDGFs), and bone morphogenetic proteins (BMP) (Kagiya, <a href="#CIT0056">2015</a>; Vinay &amp;amp; KusumDevi, <a href="#CIT0125">2016</a>). These growth factors are released from the bone matrix during the bone resorption caused by mature osteoclasts. TGF-Î² acts on cancer cells to facilitate its proliferation and production of more PTHrP. Osteoprotegerin (OPG), also produced by osteoblasts, is a soluble RANKL decoy receptor that can prevent osteoclasts formation and osteoclastic bone resorption (Wu etÂ al., <a href="#CIT0138">2020</a>). However, the production of OPG is suppressed by matric meralloproteinases (MMPs) during this â€˜vicious circleâ€™ (Lu etÂ al., <a href="#CIT0077">2009</a>). Additionally, cancer cells secrete a macrophage-stimulating protein (MSP) to promote osteoclasts activation directly via the receptor on the osteoclasts, RON tyrosine kinase (Andrade etÂ al., <a href="#CIT0007">2017</a>). The diagram description of the interaction between cells in the osteolytic microenvironment is shown in <a href="#F0002">Figure 2</a>. Also, many microRNAs are involved in osteolysis, such as miR-21, miR-133a, miR-33a, miR-190, and miR-223 (Probert etÂ al., <a href="#CIT0093">2019</a>).</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 2.</span></a></div>   <p>â€˜Vicious circleâ€™ in osteolysis caused by cancer bone metastasis.</p>   </div> <p>Nowadays, radiotherapy, surgery as well as systemic drug therapies (chemotherapy, hormone therapy), and targeted therapy are effective clinical therapies for osteolysis. The efficacy of BP appeared to be time-dependent and they were effective after 6â€"12â€‰months of therapy (Irelli etÂ al., <a href="#CIT0053">2016</a>). Denosumab is a kind of human monoclonal antibody that combines especially with RANKL to inhibit the activation of osteoclasts. Many experiments showed that Denosumab was more effective than zoledronic acid (Zol or ZA) and caused fewer side effects (Stopeck etÂ al., <a href="#CIT0111">2010</a>; Irelli etÂ al., <a href="#CIT0053">2016</a>; Chen, He, etÂ al., <a href="#CIT0014">2019</a>; Turpin etÂ al., <a href="#CIT0121">2020</a>). However, Denosumab cannot accumulate in the bone like BP and its effect is reversible after treatment discontinuation (Macedo etÂ al., <a href="#CIT0080">2017</a>).</p> </div> <div class="therapeuticagents" title="sec"><span class="label" tagx="label" title="label">3.</span><div class="title" tagx="title" title="title">
Therapeutic agents</div> <div class="chemotherapeuticdrugs" title="sec"><span class="label" tagx="label" title="label">3.1.</span><div class="title" tagx="title" title="title">
Chemotherapeutic drugs</div> <p>The theme of treating osteolysis is killing cancer cells and suppressing osteoclasts synchronously. So the optimized drug delivery systems usually loaded one kind of anticancer drugs like paclitaxel (PTX), doxorubicin (DOX), platinum (Pt), and one kind of anti-osteoclasts drugs simultaneously. Here, we emphatically introduced potent drugs and novel drugs for suppressing osteoclasts.</p> <p>BP is a stable analog of pyrophosphate by replacing the Pâ€"Oâ€"P bonds with Pâ€"Câ€"P bonds (Rudnick-Glick etÂ al., <a href="#CIT0099">2016</a>). This makes BP enzymatically stable. BP has a high affinity to the bone mineral hydroxyapatite (HA) and has been exploited as a targeting ligand. Osteoclasts can take up and be suppressed by BP chelating to bone (Zeng etÂ al., <a href="#CIT0145">2019</a>). In addition, BP has been revealed to be able to inhibit cancer cells (Robert &amp;amp; Reinhold, <a href="#CIT0097">2015</a>; Santini etÂ al., <a href="#CIT0102">2015</a>). Hydroxyapatite nanoparticles (nHA) was always applied in bone repairing because of its good biocompatibility to the bone and fine adsorption to BP. Recently, nHA has been found to be able to inhibit several kinds of cancer cells through mitochondrial-dependent apoptosis and have special functions of lessening osteolysis caused by cancer metastasis (Zhang, Zhou, etÂ al., <a href="#CIT0148">2019</a>). The transcription factor Gli2 is a key regulator of PTHrP (Vanderburgh etÂ al., <a href="#CIT0124">2019</a>). And GANT58 is a Gli2 antagonist that inhibits Gli2 nuclear translocation and PTHrP expression in tumor cells to play a role in hindering the â€˜vicious circleâ€™ (Vanderburgh etÂ al., <a href="#CIT0124">2019</a>). Gallium (Ga) is a semi-metallic element with a chemical affinity for biological HA, anti-resorption activity and anticancer ability. Ga significantly decreased osteoclasts differentiation and activity without negative interaction with osteoblasts (Strazic-Geljic etÂ al., <a href="#CIT0112">2016</a>). Odanacatib and balicatib, inhibitors of cathepsin K, can suppress bone resorption (Saracino etÂ al., <a href="#CIT0103">2016</a>). Mature osteoclasts express cathepsin K which is a kind of lysosomal cysteine protease essential for collagen and elastin degradation during bone resorption. <a href="#t0001">Table 1</a> collected some reported effective drugs for suppressing osteoclasts and some other potential drugs (Vinay &amp;amp; KusumDevi, <a href="#CIT0125">2016</a>).</p> <div class="table-wrap_UNKNOWN" id="t0001" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 1.</span> <p>The drugs with contributions to block â€˜vicious circle.â€™</p>  <table frame="hsides" rules="groups"> <colgroup> <col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup>  <thead> <tr> <th align="left">Drugs</th> <th align="center">Mechanism</th> <th align="center">Reference</th> </tr> </thead> <tbody valign="top"> <tr> <td align="left">BP</td> <td align="left">Non-nitrogen containing: inhibiting ATP hydrolysis<br /><br />Nitrogen containing: prevents protein prenylation of small GTPases</td> <td align="left">(Vinay &amp;amp; KusumDevi, <a href="#CIT0125">2016</a>);<br /><br />(Oâ€™Carrigan etÂ al., <a href="#CIT0086">2017</a>); <br /><br />(Horne etÂ al., <a href="#CIT0050">2018</a>)</td> </tr> <tr> <td align="left">Denosumab</td> <td align="left">Antibody to RANKL</td> <td align="left">(Gul etÂ al., <a href="#CIT0045">2016</a>); <br /><br />(Lipton etÂ al., <a href="#CIT0070">2016</a>); (Stopeck etÂ al., <a href="#CIT0110">2016</a>)</td> </tr> <tr> <td align="left">Odanacatib and balicatib and L-235</td> <td align="left">Inhibit cathepskin K</td> <td align="left">(Saracino etÂ al., <a href="#CIT0103">2016</a>); <br /><br />(Duong etÂ al., <a href="#CIT0032">2014</a>)</td> </tr> <tr> <td align="left">BTZ</td> <td align="left">Inhibit NF-kB pathway in osteoclast</td> <td align="left">(Zhu etÂ al., <a href="#CIT0153">2018</a>); <br /><br />(Wang, Cai, etÂ al., <a href="#CIT0126">2018</a>)</td> </tr> <tr> <td align="left">GANT58</td> <td align="left">Inhibits Gli2 nuclear translocation and PTHrP expression in tumor cells</td> <td align="left">(Vanderburgh etÂ al., <a href="#CIT0124">2019</a>);<br /><br />(Vanderburgh etÂ al., <a href="#CIT0123">2020</a>)</td> </tr> <tr> <td align="left">nHA</td> <td align="left">Mitochondrial-dependent apoptosis</td> <td align="left">(Zhang, Zhou, etÂ al., <a href="#CIT0147">2019</a>); <br /><br />(Sun, Chen, etÂ al., <a href="#CIT0114">2016</a>)</td> </tr> <tr> <td align="left">BMS-777607/ASLAN002</td> <td align="left">Inhibit MSP/RON signaling pathway</td> <td align="left">(Andrade etÂ al., <a href="#CIT0007">2017</a>)</td> </tr> <tr> <td align="left">Ga</td> <td align="left">Decrease RANKL-induced initial expression and auto-amplification of NFATc1</td> <td align="left">(Strazic-Geljic etÂ al., <a href="#CIT0112">2016</a>)</td> </tr> <tr> <td align="left">Quetiapine</td> <td align="left">Inhibiting RANKL-mediated MAPK and NF-ÎºB signaling pathways</td> <td align="left">(Wang etÂ al., <a href="#CIT0130">2015</a>)</td> </tr> <tr> <td align="left">PKI-402</td> <td align="left">Impair the PI3K-AKT-mTOR signaling pathways</td> <td align="left">(Yuan etÂ al., <a href="#CIT0144">2019</a>)</td> </tr> <tr> <td align="left">Dasatinib</td> <td align="left">Inhibit Src activity</td> <td align="left">(Irelli etÂ al., <a href="#CIT0053">2016</a>)</td> </tr> <tr> <td align="left">Chinese herbs extractions/plant extractions:</td> <td align="left">Â </td> <td align="left">Â </td> </tr> <tr> <td align="left">â€ƒLicorice isoliquiritigenin (ISL)</td> <td align="left">Anti RANKL-induced osteoclast generation</td> <td align="left">(Sun, Zhang, etÂ al., <a href="#CIT0117">2019</a>)</td> </tr> <tr> <td align="left">â€ƒCurcumin</td> <td align="left">Suppress gene <br /><br />products regulated by NF-ÎºB</td> <td align="left">(Wang, Guo, etÂ al., <a href="#CIT0127">2018</a>);<br /><br />(Yang etÂ al., <a href="#CIT0142">2020</a>);<br /><br />(An etÂ al., <a href="#CIT0006">2018</a>)</td> </tr> <tr> <td align="left">â€ƒQuercetin</td> <td align="left">Anti-oxidant</td> <td align="left">(Forte etÂ al., <a href="#CIT0037">2017</a>);<br /><br />(Zhang etÂ al., <a href="#CIT0146">2017</a>);<br /><br />(Ge etÂ al., <a href="#CIT0041">2020</a>)</td> </tr> <tr> <td align="left">â€ƒPlumbagin (PL)</td> <td align="left">Abrogated RANKL-induced NF-ÎºB and MAPK pathways by blocking RANK association with TRAF6 in osteoclastogenesis</td> <td align="left">(Qiao etÂ al., <a href="#CIT0094">2017</a>); <br /><br />(Li etÂ al., <a href="#CIT0067">2012</a>)</td> </tr> <tr> <td align="left">â€ƒArtemisinin, Dihydroartemisinin</td> <td align="left">Reduced expression of genes involved in osteoclast formation, suppressed osteoclast differentiation, F-actin ring formation and bone resorption through suppressing AKT/SRC pathways</td> <td align="left">(Ma etÂ al., <a href="#CIT0079">2018</a>); <br /><br />(Li etÂ al., <a href="#CIT0066">2019</a>);<br /><br />(Feng etÂ al., <a href="#CIT0034">2016</a>)</td> </tr> <tr> <td align="left">â€ƒRaddeanin A</td> <td align="left">Inhibit SRC/AKT signaling pathway;</td> <td align="left">(Wang, Mo, etÂ al., <a href="#CIT0129">2018</a>)</td> </tr> <tr> <td align="left">â€ƒPlatycodin D</td> <td align="left">Blocked RANKL-induced osteoclast formation by inhibiting the expression and nuclear translocation of NFATc1 and c-Fos in BMMs; inhibited the growth of MDA-MB-231 cells</td> <td align="left">(Lee etÂ al., <a href="#CIT0065">2015</a>)</td> </tr> <tr> <td align="left">â€ƒwedelolactone</td> <td align="left">Inhibit Akt/mammalian target of the rapamycin signaling pathway (mTOR); suppress NF-ÎºB/c-fos/NFATc1 pathway</td> <td align="left">(Hsieh etÂ al., <a href="#CIT0051">2015</a>); <br /><br />(Liu, Hong, etÂ al., <a href="#CIT0072">2016</a>)</td> </tr> <tr> <td align="left">â€ƒThymoquinone</td> <td align="left">Suppress NF-KB and MAPK signaling</td> <td align="left">(Thummuri etÂ al., <a href="#CIT0120">2015</a>)</td> </tr> <tr> <td align="left">â€ƒBrucine</td> <td align="left">Suppress Jagged1/Notch1 Signaling Pathways;<br /><br />Increase both the OPG mRNA/RANKL mRNA expression ratio and the OPG protein/RANKL protein ratio</td> <td align="left">(Hu etÂ al., <a href="#CIT0052">2017</a>); <br /><br />(Wu etÂ al., <a href="#CIT0139">2017</a>)</td> </tr> <tr> <td align="left">â€ƒbenzyl isothiocyanate</td> <td align="left">Down-regulate RANKL and runt-related transcription factor 2 (RUNX2)</td> <td align="left">(Pore etÂ al., <a href="#CIT0091">2018</a>)</td> </tr> <tr> <td align="left">â€ƒCamellia sinensis</td> <td align="left">Anti-oxidant</td> <td align="left">(Luo etÂ al., <a href="#CIT0078">2015</a>)</td> </tr> <tr> <td align="left">â€ƒSinomenine</td> <td align="left">Reducing IL-8/CXCR1 and c-Fos/NFATc1 signaling</td> <td align="left">(Zhang, Zou, etÂ al., <a href="#CIT0148">2019</a>)</td> </tr> </tbody> </table> </div> <p>Some traditional Chinese herb extractions were studied for their ability to inhibit the activation of osteoclast induced by cancer cells and obtained optimistic results, as showed in <a href="#t0001">Table 1</a>. Curcumin, extraction from <i>Curcuma longa</i> plant, was able to anti-inflammatory and anti-cancer cells through NOTCH-1 signaling and suppress NF-ÎºB relative gene expression. Artemisinin and its derivants, famous for curing malaria, were also researched about their inhibiting osteolysis and cancer ability. Dihydroartemisinin suppressed osteoclasts differentiation, F-actin ring formation, and bone resorption through AKT/SRC pathways. It also inhibited breast tumor-induced osteolysis by inhibiting the proliferation, migration and invasion of MDA-MB-231 cells via modulating AKT signaling pathway. Wedelolactone, a natural product from <i>Ecliptae herba</i>, was reported to be capable of suppressing breast cancer-induced osteoclastogenesis and enhancing osteoblastogenesis. And some extractions were revealed effective in suppressing osteoclasts formation and maturity without a clear mechanism yet. In spite of the satisfying experimental outcome, drugsâ€™ low bioavailability, poor solubility, and short half-life limit their application (Wang, Sun, etÂ al., <a href="#CIT0114">2016</a>).</p> <p>In addition to the routine anticancer chemotherapeutic drug, photothermal agents (PTA) have aroused great interest of scientists because of their good photothermal conversion ability which is fundamental for the physical therapy of cancer.</p> </div> <div class="photothermalmaterials" title="sec"><span class="label" tagx="label" title="label">3.2.</span><div class="title" tagx="title" title="title">
Photothermal materials</div> <p>NIR, which is absorbed in minimal amounts by water and biomolecules, can penetrate tissue deeply (Chen, Ning, etÂ al., <a href="#CIT0016">2019</a>). First NIR window light (650â€"950â€‰nm) is often utilized in photothermal therapy (PTT). Exposed to NIR radiation, PTA can generate heat through plasmon resonance or jump energy to rapidly increase the local temperature to ablate cancer cells. Cancer cells are more sensitive to heat than surrounding normal cells and more likely to be damaged with the cells membrane, intracellular protein, or RNA/DNA repair being broken (Abadeer &amp;amp; Murphy, <a href="#CIT0001">2016</a>). Regional hyperthermy can kill cells and increase the cellsâ€™ sensitivity to anticancer drugs (Sun, Ge, etÂ al., <a href="#CIT0115">2019</a>). Frequently-used PTA include inorganic materials (noble metal materials, transition-metal chalcogenide materials, carbon-based nanomaterials etc.) and organic materials (polypyrrole and polydopamine, cyanine dyes, porphyrin, etc.). Gold NPs, Pt NPs, Fe<sub>3</sub>O<sub>4</sub> NPs, and carbon-based nanomaterials have been explored as PTA because of their effective photothermal conversion (Liu, Bhattarai, etÂ al., <a href="#CIT0071">2019</a>; Zhao etÂ al., <a href="#CIT0149">2020</a>). Polydopamine (PDA) is formed by mussel-inspired polymerization dopamine. PDA possesses not only versatile adhesion property (through covalent binding or non-covalent binding of catecholamine groups coordination or chelation) which can be utilized to modify the surface of various materials and bind drugs, high chemical activity, excellent biocompatibility, but also strong photothermal property. The biodegradable monodispersed bioactive glass (BGN) was modified by PDA and linked DOX to these NPs for enhancing colon cancer photothermo-chemotherapy and bone repair. NIR-excited PTT of BGN@PDA could ablate tumors. And the relative tumor volume was reduced to 0.85 in BGN@PDA-DOX group, 0.50 in BGN@PDAâ€‰+â€‰NIR group, and 0.01 in BGN@PDA-DOXâ€‰+â€‰NIR group after 12Â d of treatment. <i>In vivo</i> experiment and quantitative analysis revealed that BGN@PDA and BGN could enhance new bone formation, and NIR did not reduce the bone regeneration efficacy of BGN@PDA (Xue etÂ al., <a href="#CIT0140">2020</a>). In another study, the researcher fabricated a kind of ALN-conjugated PDA NPs (PDA-ALN), which exhibited excellent photothermal effect and high affinity to HA. PDA-ALN loaded anticancer drug 7-ethyl-10-hydroxycamptothecin (SN38) via Ï€â€"Ï€ stacking and the release of SN38 could be triggered by NIR. <a href="#F0003">Figure 3(a)</a> showed the mechanism of these multifunctional NPs. The combination of PTT (43â€‰Â°C) and chemotherapy in this smart and targeted delivery system suppressed the breast tumorâ€™s growth in bone and lessened the osteolytic destruction (<a href="#F0003">Figure 3(b)</a>; Wang, Huang, etÂ al., <a href="#CIT0128">2018</a>).</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 3.</span></a></div>   <p>(a) Illustration of bone-targeted NPs with chemo-photothermal treatment. (b) 3D micro-CT reconstruction image of the tumor-bearing tibias after several treatment (Wang, Huang, etÂ al., <a href="#CIT0128">2018</a>).</p>   </div> <p>Besides, some interesting photothermal materials with smart decoration were synthesized and applied in targeted delivery systems. Na<sub>x</sub>WO<sub>3</sub> NPs (about 150â€‰nm oxygen vacancy-rich tungsten bronze NPs) were synthesized for PTT. Na<sub>x</sub>WO<sub>3</sub> NPs had desirable PTT effects that the temperature increased from 25.8â€‰Â°C to 41.8â€‰Â°C in 5â€‰min under the irradiation of 980â€‰nm laser. The cytotoxicity of the particles against breast cancer cells appeared in dose-dependence <i>inÂ vitro</i>. In breast cancer models, Na<sub>x</sub>WO<sub>3</sub> + PTT group had the most effective inhibition of tumor and bone destruction (Jie etÂ al., <a href="#CIT0055">2019</a>). Except for organic photothermal materials, noble metal and inorganic materials both have nonnegligible cytotoxicity, low biodegradability and low biocompatibility. Effective PTT needs the desired accumulation of PTA in the irradiated area. Thus, it is necessary to apply targeted or local drug delivery systems to carry these PTA to narrow their distribution and modify them to improve biocompatibility.</p> </div> </div> <div class="drugdistributionoptimization" title="sec"><span class="label" tagx="label" title="label">4.</span><div class="title" tagx="title" title="title">
Drug distribution optimization</div> <div class="targeteddelivery" title="sec"><span class="label" tagx="label" title="label">4.1.</span><div class="title" tagx="title" title="title">
Targeted delivery</div> <p>As just mentioned, anticancer treatment is the foundation of anti-metastatic osteolysis but inadequate without specific distribution in the osteolytic part or synergy with anti bone resorption drugs. Optimized targeted delivery systems usually rely on NPs which could target metastatic bone and carry anticancer or anti-osteolysis drugs efficiently via targeting ligands. <a href="#t0002">Table 2</a> listed the collected targeted drug delivery systems. Through systemic administration methods like intravenous injection, targeted delivery systems narrow the drugâ€™s distribution to the bone, tumor, or osteolytic site. The ligands like BP, tetracycline, chelating compounds, salivary proteins, Alizarin Red S, and oligopeptides (oligo-aspartic acid) have an affinity to bone (de Miguel etÂ al., <a href="#CIT0027">2014</a>; Chang etÂ al., <a href="#CIT0012">2016</a>; Ryu etÂ al., <a href="#CIT0100">2016</a>; Stapleton etÂ al., <a href="#CIT0109">2017</a>). In the affinity assay for HA <i>inÂ vitro</i>, 77.5% of alendronate (ALN, Ald, or Alen) bound to HA powder (Ryu etÂ al., <a href="#CIT0100">2016</a>). Zol exhibited 20-fold increased targeting of bone metastatic lesions than other major tissues (Hatami etÂ al., <a href="#CIT0047">2019</a>). BP was used mostly to modify the designed NPs which encapsulated anticancer drugs. With BP, NPs can target bone and release anticancer drugs to inhibit cancer cells and suppress osteoclasts. Loaded drugs can be chemically conjugated to the nanocarriers or physically encapsulated or adsorbed and released by diffusion, erosion of carriers or the break of chemical bonds (Zeng etÂ al., <a href="#CIT0145">2019</a>). The physicochemical property of these targeted nanocarriers makes a difference in their application (Danaei etÂ al., <a href="#CIT0025">2018</a>). The size of nanocarriers cannot exceed 400â€‰nm in order to escape from macrophage and renal clearance and are preferably less than 200â€‰nm (Perez-Herrero &amp;amp; Fernandez-Medarde, <a href="#CIT0090">2015</a>). Smaller NPs can help them through the openings of the boneâ€™s sinusoidal capillaries (10â€"70â€‰nm). Small neutral NPs (about 150â€‰nm) were also 7-fold more effective in localizing in bone marrow than large NPs (about 320â€‰nm; Adjei etÂ al., <a href="#CIT0002">2016</a>). Nanocarriers between 70 and 100â€‰nm were often used to target bone for their extended blood circulating time (Adjei etÂ al., <a href="#CIT0002">2016</a>). The nanocarriers with hydrophilic, neutral, or slightly anionic surfaces are more prone to localize in the bone marrow and escape from the macrophage attack by avoiding plasma proteins. A neutral surface charge is achieved by modulating the surface-associated emulsifier composition. Hydrophilic surface can be obtained by decoration with hydrophilic polymers like poly(ethylene glycol) (PEG) or amphiphilic polymers like synthetic copolymers of polyethylene oxide (hydrophilic block) and propylene oxide (hydrophobic block) (Perez-Herrero &amp;amp; Fernandez-Medarde, <a href="#CIT0090">2015</a>; Suk etÂ al., <a href="#CIT0113">2016</a>). Targeted drug delivery systems have been developed based on polymer NPs, micelles, liposomes, Silica NPs, inorganic compounds (HA nanocrystal, calcium phosphates NPs, etc.), or organometallic compounds. Polymer NPs were used most frequently in drug release systems for their good biocompatibility and biodegradability and drugs were released through NPs erosion. Related synthetic polymers include polyglutamic acid, polyglycolic acid (PGA), PEG, polycaprolactone (PCL), polylactic acid (PLA), poly aspartate (PAA), poly(D, L-lactide-co-glycolic) acid (PLGA), and N-(2-hydroxypropyl)-methacrylamide copolymer (HPMA) Ulbrich etÂ al., <a href="#CIT0122">2016</a>). Natural polymers include chitosan (CS), alginate, dextran, heparin, albumin, gelatin, and collagen (George etÂ al., <a href="#CIT0042">2019</a>).</p> <div class="table-wrap_UNKNOWN" id="t0002" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 2.</span> <p>Designed targeted drug delivery systems based on nanomaterials or nanotechnology and their release characteristics.</p>  <table frame="hsides" rules="groups"> <colgroup> <col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup>  <thead> <tr> <th align="left">Classification</th> <th align="center">Loaded drugs</th> <th align="center">Ligand</th> <th align="center">Target</th> <th align="center">Trigger</th> <th align="center">PTT</th> <th align="center">Reference</th> </tr> </thead> <tbody valign="top"> <tr> <td rowspan="3">MSNs</td> <td align="left">DOX, ZOL</td> <td align="left">ZOL</td> <td align="left">Bone</td> <td align="left">pH</td> <td align="left">Â </td> <td align="left">(Sun, Han, etÂ al., <a href="#CIT0116">2016</a>)</td> </tr> <tr> <td align="left">PL, ZOL</td> <td align="left">ZOL</td> <td align="left">Bone</td> <td align="left">pH</td> <td align="left">Â </td> <td align="left">(Qiao etÂ al., <a href="#CIT0094">2017</a>)</td> </tr> <tr> <td align="left">ZOL, Au</td> <td align="left">ZOL</td> <td align="left">Bone</td> <td align="left">Â </td> <td align="left">Yes</td> <td align="left">(Sun, Ge, etÂ al., <a href="#CIT0115">2019</a>)</td> </tr> <tr> <td align="left">Calcium phosphate NPs</td> <td align="left">MTX, ALN</td> <td align="left">ALN</td> <td align="left">Bone</td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">(Chu etÂ al., <a href="#CIT0021">2017</a>)</td> </tr> <tr> <td rowspan="2">Liposome</td> <td align="left">DOX</td> <td align="left">Asp8, folate</td> <td align="left">FR, bone</td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">(Ke etÂ al., <a href="#CIT0059">2017</a>)</td> </tr> <tr> <td align="left">ALN, DOX</td> <td align="left">ALN, hyaluronic acid</td> <td align="left">CD44, bone</td> <td align="left">Redox</td> <td align="left">Â </td> <td align="left">(Feng etÂ al., <a href="#CIT0035">2019</a>)</td> </tr> <tr> <td align="left">nMOFs</td> <td align="left">ZOL</td> <td align="left">Folate</td> <td align="left">FR</td> <td align="left">pH</td> <td align="left">Â </td> <td align="left">(Au etÂ al., <a href="#CIT0009">2016</a>)</td> </tr> <tr> <td align="left">Bioactive glass NPs</td> <td align="left">DOX</td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">pH, NIR</td> <td align="left">Yes</td> <td align="left">(Xue etÂ al., <a href="#CIT0140">2020</a>)</td> </tr> <tr> <td rowspan="4">Micelles</td> <td align="left">ALN, curcumin</td> <td align="left">ALN, Oligosaccharide of hyaluronan</td> <td align="left">CD44, bone</td> <td align="left">Redox</td> <td align="left">Â </td> <td align="left">(Wang, Guo, etÂ al., <a href="#CIT0127">2018</a>)</td> </tr> <tr> <td align="left">BTZ, ALN</td> <td align="left">ALN</td> <td align="left">Bone</td> <td align="left">pH</td> <td align="left">Â </td> <td align="left">(Zhu etÂ al., <a href="#CIT0153">2018</a>)</td> </tr> <tr> <td align="left">Docetaxel</td> <td align="left">Quinolone nonpeptide</td> <td align="left">IntegrinaVÎ²3</td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">(Ross etÂ al., <a href="#CIT0098">2017</a>)</td> </tr> <tr> <td align="left">DTX, ALN</td> <td align="left">ALN</td> <td align="left">Bone</td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">(Liu, Romanova, etÂ al., <a href="#CIT0073">2019</a>)</td> </tr> <tr> <td align="left">QD</td> <td align="left">ALN, DOX</td> <td align="left">ALN</td> <td align="left">Bone</td> <td align="left">pH</td> <td align="left">Â </td> <td align="left">(Li etÂ al., <a href="#CIT0068">2017</a>)</td> </tr> <tr> <td align="left">Tungsten bronze nanoparticles</td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">Yes</td> <td align="left">(Jie etÂ al., <a href="#CIT0055">2019</a>)</td> </tr> <tr> <td rowspan="8">Polymeric NP</td> <td align="left">DOX, ALN</td> <td align="left">ALN</td> <td align="left">Bone</td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">(Rudnick-Glick etÂ al., <a href="#CIT0099">2016</a>)</td> </tr> <tr> <td align="left">Cabazitaxel, ALN</td> <td align="left">ALN</td> <td align="left">Bone</td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">(Gdowski etÂ al., <a href="#CIT0040">2017</a>)</td> </tr> <tr> <td align="left">ZOL</td> <td align="left">ZOL</td> <td align="left">Bone</td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">(Hatami etÂ al., <a href="#CIT0047">2019</a>)</td> </tr> <tr> <td align="left">GANT58, ALN</td> <td align="left">ALN</td> <td align="left">Bone</td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">(Vanderburgh etÂ al., <a href="#CIT0123">2020</a>)</td> </tr> <tr> <td align="left">DOX, ALN</td> <td align="left">ALN, hyaluronic acid</td> <td align="left">Bone, CD44</td> <td align="left">pH, redox</td> <td align="left">Â </td> <td align="left">(Zhao etÂ al., <a href="#CIT0150">2017</a>)</td> </tr> <tr> <td align="left">GANT58</td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">ROS</td> <td align="left">Â </td> <td align="left">(Vanderburgh etÂ al., <a href="#CIT0124">2019</a>)</td> </tr> <tr> <td align="left">PTX, ALN</td> <td align="left">ALN, folate</td> <td align="left">Bone, FR</td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">(Chen etÂ al., <a href="#CIT0015">2020</a>)</td> </tr> <tr> <td align="left">SN38, ALN</td> <td align="left">ALN</td> <td align="left">Bone</td> <td align="left">pH, NIR</td> <td align="left">Yes</td> <td align="left">(Wang, Huang, etÂ al., <a href="#CIT0128">2018</a>)</td> </tr> <tr> <td rowspan="3">Dendrimer</td> <td align="left">Pt NPs</td> <td align="left">Carboxyl terminals</td> <td align="left">Bone</td> <td align="left">Â </td> <td align="left">Yes</td> <td align="left">(Yan etÂ al., <a href="#CIT0141">2019</a>)</td> </tr> <tr> <td align="left">BTZ</td> <td align="left">RGD</td> <td align="left">IntegrinaVÎ²3</td> <td align="left">pH</td> <td align="left">Â </td> <td align="left">(Wang, Cai, etÂ al., <a href="#CIT0126">2018</a>)</td> </tr> <tr> <td align="left">DTX, ALN</td> <td align="left">ALN, hyaluronic acid</td> <td align="left">Bone, CD44</td> <td align="left">pH, redox</td> <td align="left">Â </td> <td align="left">(Bai etÂ al., <a href="#CIT0010">2019</a>)</td> </tr> </tbody> </table> </div> <div class="monotargetdelivery" title="sec"><span class="label" tagx="label" title="label">4.1.1.</span><div class="title" tagx="title" title="title">
Mono target delivery</div> <p>Most targeted NPs had only one kind of targeting ligands decorated to combine with one specific molecular structure in the osteolytic microenvironment. PLGA and cabazitaxel were used as the core with amino-BP surface conjugation to make NPs. Bone-targeted NPs showed an 8-fold affinity to the bone in 72â€‰h compared with non-targeted NPs. After one-month treatment of bone metastatic models, only the targeted NPs treatment group had a significant reduction in limb weight and pain response. And targeted NPs provided all treated mice protection from bone lesions while 33% of the mice with nontargeted NPs treatment had bone lesions (Gdowski etÂ al., <a href="#CIT0040">2017</a>). Similarly, polymeric NPs or micelles encapsulating anticancer drugs, functionalized with ZA or ALN for homing bone, were designed in many other studies and demonstrated much higher efficiency and accumulation in bone than free drugs (Rudnick-Glick etÂ al., <a href="#CIT0099">2016</a>; Hatami etÂ al., <a href="#CIT0047">2019</a>; Liu, Romanova, etÂ al., <a href="#CIT0073">2019</a>). A novel preparation of polymeric NPs with high affinity to bone was completed by Yuya Hirano etÂ al. (Hirano &amp;amp; Iwasaki, <a href="#CIT0048">2017</a>). Two-step synthesis of cholesteryl-functionalized poly(ethylene sodium phosphate) (Ch-PEPnÂ·Na) was performed via ring-opening polymerization of cyclic phosphoesters and the demethylation. Synthesized PEPnÂ·Na NPs adsorbed onto HA with the help of poly(ethylene sodium phosphate) which is an analog of polyphosphoesters and has a polyphosphodiester backbone. Scanning electron microscopy images demonstrated PEPnÂ·Na NPs had a higher affinity to the bone than PEG NPs. In addition to polymeric NPs, calcium phosphate NPs and multi-walled carbon nanotubes were also utilized as BP-modified drug delivery systems to target bone (Chu etÂ al., <a href="#CIT0021">2017</a>; Dlamini etÂ al., <a href="#CIT0029">2019</a>). It was reported that carboxyl groups on the dendrimer surface endowed dendrimer with the intrinsic bone-binding affinity (Yan etÂ al., <a href="#CIT0141">2019</a>). The dendrimer loaded with Pt NPs (DEPt-COOH) showed a high affinity to HA and bone fragments <i>inÂ vitro</i> and was able to selectively recognize the osteolytic bone lesions <i>inÂ vivo</i> (Yan etÂ al., <a href="#CIT0141">2019</a>). Polyphosphate (polyP) was also used in a bone-targeted system. Ca-polyP nano/microparticles complexed with ZA maintained the morphogenesis and mineralization-inducing activity of polyP and anti-osteolysis effect of BP (MÃ¼ller etÂ al., <a href="#CIT0082">2018</a>). Optimized PTT systems usually depended on targeted NPs or locally implanted materials to increase PTT efficiency and reduce the toxicity to other organs because PTA are hard to degrade. For example, Gold nanorods were enclosed inside targeted mesoporous silica NPs (MSNs NPs) for PTT and obtained obvious treatment effects (Sun, Ge, etÂ al., <a href="#CIT0115">2019</a>).</p> </div> <div class="dualtargetdelivery" title="sec"><span class="label" tagx="label" title="label">4.1.2.</span><div class="title" tagx="title" title="title">
Dual target delivery</div> <p>BP modified drug delivery systems targeted both healthy and destructed bones no matter whether cancer metastasis happened. Adding the targets of delivery systems is an effective way to improve the accuracy of targeting. For instance, designed NPs may contain two types of target ligands that target bone and tumor cells respectively. Dual-targeted or even multi-targeted drug delivery systems rely on the discovery of cellsâ€™ special expression or special molecular structure in the osteolytic microenvironment. It was found that bone metastatic cancer cells overexpress folate receptor (FR), cluster of differentiation 44 (CD44) and integrin Î±VÎ²3. Human cells express and depend on FR to uptake exogenous folate. FR is widely expressed in normal and tumor cells but more in quantity and activity in tumor cells. In tumor cells, FR loses polarity and becomes easier for drugs in circulation to approach. Folate is a target ligand for FR and is often used to modify the targeted NPs synergistically with BP to target metastatic bone lesions (Assaraf etÂ al., <a href="#CIT0008">2014</a>; Au etÂ al., <a href="#CIT0009">2016</a>). Shih-Hong Chen etÂ al. designed an NPs-based dual-targeted delivery system comprising hydrophobic PLGA core and ALN-modified, folic acid-conjugated D-a-tocopheryl polyethylene glycol succinate (TPGS) coat to deliver PTX. PTX-loaded dual-targeted NPs evidently accumulated in bone metastases after intravenous injection and exhibited the highest efficiency of inhibiting 4T1 tumor growth. It retarded bone destruction of the tumor-bearing mice appreciably with significant improvement of the survival rate of treated mice (median survival &amp;gt;50Â d, but &amp;lt;35Â d in other groups; Chen etÂ al., <a href="#CIT0015">2020</a>). In another work, aspartate which possesses affinity to the bone because of the similar HA-binding domain of osteopontin and osteocalcin, and folate were used to conjugate onto the surface of DOX-loaded liposomes. Fluorescent images (<a href="#F0004">Figure 4</a>) demonstrated that dual-targeted liposomes optimized the liposome accumulation in cancer metastatic bone (Ke etÂ al., <a href="#CIT0059">2017</a>). CD44 is one kind of transmembrane glycoprotein that binds with extracellular matrix hyaluronic acid to mediate intracellular signaling. It is overexpressed in tumor cells and plays an important role in tumor metastasis and invasion. Hyaluronic acid, as a specific ligand for CD44 receptor, was used in many targeted delivery systems (Dosio etÂ al., <a href="#CIT0031">2016</a>; Bai etÂ al., <a href="#CIT0010">2019</a>). Kaili Wang etÂ al. fabricated CD44 and bone dual-targeted nano micelles via a series of esterification reactions, with oligosaccharides of hyaluronan targeting CD44 and ALN targeting bone. <i>In vivo</i> distribution experience, dual-targeted micelles group had higher distribution to the bone than other groups (Wang, Guo, etÂ al., <a href="#CIT0127">2018</a>). Another work about DOX-loaded bone and CD44-dual-targeted delivery system showed that the signals of dual-targeting group peaked at 2â€‰h after injection, quicker than the CD44-single-targeting group (6â€‰h). The median survival time was extended to 67Â d from 30Â d for the untreated group (Feng etÂ al., <a href="#CIT0035">2019</a>). These results showed that dual-targeted delivery systems have a stronger ability to target metastatic bone, further optimized the distribution of drugs. Integrin Î±VÎ²3 is expressed rarely in normal cells but highly in tumor cells and neoplastic neovascular endothelial cells. It can activate matrix metalloproteinase 2 (MMP-2) and accelerate tumor cells secreting cell adherence molecule which contributes to tumor metastasis and neoplastic neovascular formation. ITGÎ²3 (a subunit of integrin Î±VÎ²3) is over-expressed in bone metastatic cancer cells compared to cancer cells from other metastatic organs such as liver, lymph nodes (Ross etÂ al., <a href="#CIT0098">2017</a>; Gdowski etÂ al., <a href="#CIT0039">2019</a>). ITGÎ²3 is a critical factor that contributes to the ability of cancer cells to specifically home and bind to endothelial cells in bone (Kwakwa &amp;amp; Sterling, <a href="#CIT0063">2017</a>). This targeting bone function of integrin was exploited to engineer a programmable-bioinspired NPs (P-BiNP) to target bone and increase uptake in homotypic tumor cells (Gdowski etÂ al., <a href="#CIT0039">2019</a>). Researchers employed chemokine factor motif chemokine ligand 12 (CXCL12) to stimulate cancer cells to express more integrin, and purified cancer cell membranes to carry PLGA NPs. <i>In vivo</i> bone homing experiment, P-BiNP had an increased affinity to the bone and decreased affinity to other organs compared to the BiNPs (Gdowski etÂ al., <a href="#CIT0039">2019</a>). On the other hand, integrin Î±VÎ²3 can be a target and recognized by tripeptide Argâ€‰âˆ’â€‰Glyâ€‰âˆ’â€‰Asp (RGD) and quinolone nonpeptide specifically (Wang, Cai, etÂ al., <a href="#CIT0126">2018</a>). Michael H. Ross etÂ al. used quinolone nonpeptide to decorate phospholipid/polysorbate-80 micelle NPs which loaded DOX and demonstrated a stronger accumulation in bone metastases than nontargeted NPs through immunofluorescent analysis <i>inÂ vivo</i> (Ross etÂ al., <a href="#CIT0098">2017</a>). Well-design and mature technology are required for linking two kinds of ligands to nanocarriers. And whether dual-targeted systems could have better biodistribution still needs to be experimented.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 4.</span></a></div>   <p>Biodistribution of various liposomes containing Cy5.5 in mice bearing MDA-MB-231 tumors determined by an IVIS Spectrum-CT (Ke etÂ al., <a href="#CIT0059">2017</a>).</p>   </div> </div> </div> <div class="localdelivery" title="sec"><span class="label" tagx="label" title="label">4.2.</span><div class="title" tagx="title" title="title">
Local delivery</div> <p>Through the systemic administration, targeted NPs arrive at the destination with the help of the bloodstream. The degradation and drug release of miss-targeted particles may impact the liver or kidney consequently (Chew &amp;amp; Danti, <a href="#CIT0020">2017</a>). However, the implanted drug-loading materials deliver drugs directly and locally in implanted position, escaping the â€˜dangerâ€™ in the bloodstream without facing the blood marrow barrier. Some studies revealed that bone metastasis models treated with locally administered ZA obtained a statistically significant increase in bone volume/tissue volume compared with treatment with systemic ZA administration (Nooh etÂ al., <a href="#CIT0084">2017</a>; Ahangar etÂ al., <a href="#CIT0003">2018</a>). Local drug delivery systems can further improve drugsâ€™ curative efficiency. These systems rely on implantable biomaterials and implantation operation, maximize the therapy efficiency of drugs, and minimize the toxicity to other organs (Newman &amp;amp; Benoit, <a href="#CIT0083">2016</a>). They can reduce the frequency of drug administration because of a large number of drugs loaded and more sustained release, but run the risk of infection and inflammation after implantation (Sarigol-Calamak &amp;amp; Hascicek, <a href="#CIT0105">2018</a>). When the tumors in bone marrow develop and cause bone destruction, the operation is necessary. After tumor resection, bone grafts are always implanted as a substitute for destroyed bone (Chen, Boda, etÂ al., <a href="#CIT0013">2018</a>), but not enough to inhibit ongoing osteolysis and residual cancer cell proliferation. Therefore, these implanted materials can be modified as multifunctional local drug delivery systems to prevent further bone resorption in subsequent therapy and as bone grafts for the support of the bone function. The implantable materials for lessening osteolysis mainly included scaffolds and porous composite that need to be surgically implanted and locally injected self-assembly hydrogel. Titanium, polymers, calcium phosphate, CS, collagen, hyaluronic acid, alginate were commonly used to fabricate or modify these implantable materials. Solid-state processing (powder metallurgy, sintering of powders and fibers), liquid state processing (direct foaming and spray foaming), vapor deposition, and electrode position were exploited to fabricate porous materials (Sarigol-Calamak &amp;amp; Hascicek, <a href="#CIT0105">2018</a>). 3D-print technology (Do etÂ al., <a href="#CIT0030">2015</a>; Wang etÂ al., <a href="#CIT0132">2020</a>) and electrospinning (Chen, Boda, etÂ al., <a href="#CIT0013">2018</a>) were also employed to fabricate 3D multifunctional scaffolds (Yu etÂ al., <a href="#CIT0143">2016</a>). Porosity, biodegradability, swelling, and mechanical property of materials have an effect on local drug delivery manner (Chen, Boda, etÂ al., <a href="#CIT0013">2018</a>; Wu etÂ al., <a href="#CIT0136">2018</a>).</p> <div class="implantablescaffoldorcomposite" title="sec"><span class="label" tagx="label" title="label">4.2.1.</span><div class="title" tagx="title" title="title">
Implantable scaffold or composite</div> <p>The most common way to optimize the grafts for treating osteolysis is decorating them with anti-osteolysis drugs. For example, ZOL-loaded bone cement or tricalcium phosphate (TCP) inhibited malignant bone tumors or metastatic bone tumors with the help of sustained ZOL release and acted as a bone substitute at the same time (Koto etÂ al., <a href="#CIT0061">2017</a>; Rahmanian etÂ al., <a href="#CIT0095">2017</a>). Aliphatic polyesters like PCL, PLA, PLLA were used widely for their good biodegradability, biocompatibility, and permeability (Oledzka etÂ al., <a href="#CIT0087">2017</a>). Ewa Oledzka etÂ al. prepared a new multifunctional composite as a promising bone substitute material in which HA porous granules doped with selenite ions (SeO<sub>3</sub><sup>2âˆ’</sup>) and conjugated biodegradable branched copolymer-BP. This composite delivered pamidronate locally to inhibit bone resorption and osteoclast activity. The different molar ratios of copolymers (PLLA/PCL) resulted in different drug release kinetics and degradation speed (Oledzka etÂ al., <a href="#CIT0087">2017</a>). In another work, PCL matrix and multilayer polyelectrolyte were combined to fabricate a scaffold in which CaCO<sub>3</sub> microparticles were covered with multilayer polyelectrolyte and then loaded with dexamethasone (DXM) for sustained local release. As a drug delivery system, this PCL scaffold also promoted osteoblast-like cells (PalamÃ etÂ al., <a href="#CIT0089">2017</a>). 3D-print technology is popular in medicine and bionics. It has been used extensively in fabricating individualistic, multifunctional scaffolds and given the inspiration to design local drug release systems. In the work of Pouyan Ahangar etÂ al., 3D-printed scaffolds which loaded and locally delivered DOX to inhibit cancer cells could also potentially serve as a substitute for destructed bone tissue (Ahangar etÂ al., <a href="#CIT0003">2018</a>). Commonly applied for the repair and replacement of bone in the clinic, titanium is often utilized to fabricate 3D bone scaffolds in researches (Wang etÂ al., 2019). Kun Zhang etÂ al. fabricated a 3D-printed multifunctional titanium scaffold with an anti-tumor function via modification of locally-released nHA. After 5â€‰weeks of implantation, <i>in-situ</i> tumor volume of the rabbit implanted with nHA/titanium scaffold was 73.8% smaller than other groups. Micro-CT showed nHA/titanium scaffold inhibited osteolytic destruction (<a href="#F0005">Figure 5(a)</a>). New bone formed at the pore walls of the nHA/titanium scaffold (<a href="#F0005">Figure 5(b))</a> (Zhang, Zhou, etÂ al., <a href="#CIT0148">2019</a>). Another optimized implantable titanium scaffold was fabricated with titania nanotube arrays to form nano-engineered 3D titanium wire. TNF-related apoptosis-inducing ligand (TRAIL) was loaded onto titania nanotube arrays (Ti-TNT) to form TRAIL-TNTs for localized cancer treatment (Song etÂ al., <a href="#CIT0108">2018</a>). The mechanical property and microstructure of TRAIL-TNTs made it proper to support bone and act as a substitute graft with local treatment after cancer resection. Type I collagen and calcium salt are the main ingredients of bone. Thus, composites containing some similar nature polymers and calcium salt possess good biocompatibility and outstanding ability to induce osteogenesis. Mehdi Rahmanian etÂ al. developed a gelatin/beta-TCP (Î²-TCP) nanocomposite scaffold loaded with ZA for bone defect regeneration and local drug release after cancer resection. Porous structure (50â€"200â€‰Î¼m pore) of gelatin reinforced with Î²-TCP spherical NPs (around 90â€‰nm diameter) facilitated bone cell proliferation. Local ZA release not only inhibited the residual cancer cells and osteoclasts but also promoted osteoblasts proliferation. Histopathological results showed that the new bone formation was established by more than 75% in the whole area of the defect after 3 and 4â€‰months (Rahmanian etÂ al., <a href="#CIT0096">2019</a>). PTT can collaborate with implantable scaffold logically and naturally. Fe<sub>3</sub>O<sub>4</sub> NPs and hydrated GdPO<sub>4</sub> nanorods were incorporated in bioactive CS matrix to form multifunctional GdPO<sub>4</sub>/CS/Fe<sub>3</sub>O<sub>4</sub> scaffolds for tumor PTT and bone tissue regeneration. The Fe<sub>3</sub>O<sub>4</sub> NPs improved NIR absorption capacity and photothermal conversion efficiency. After 10â€‰min of NIR laser irradiation, the temperature of GdPO<sub>4</sub>/CS/Fe<sub>3</sub>O<sub>4</sub> scaffolds arrived at 47.7â€‰Â°C and the local temperature around the GdPO<sub>4</sub>/CS/Fe<sub>3</sub>O<sub>4</sub> scaffolds arrived up to 45.4â€‰Â°C within 20â€‰s. The tumor diameter in GdPO<sub>4</sub>/CS/Fe<sub>3</sub>O<sub>4</sub> treatment group decreased with the therapy time extension. Hydrated GdPO<sub>4</sub> nanorods served as a novel bioactive component for enhancing angiogenesis and osteogenesis. The scaffolds also promoted the osteogenic related gene expression and bone regeneration (Zhao etÂ al., <a href="#CIT0149">2020</a>). Multifunctional scaffolds have certain mechanical properties and space structures and these make them only apply to the severe metastatic bone defect area which need surgery.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 5.</span></a></div>   <p>(a) Micro-CTâ€"reconstructed images of the implants and adjacent bone tissue. B: bone; S: scaffold; arrows show adjacent cortical bone resorption by tumor. (b) Histological observation of the implanted scaffolds. S: scaffold; T: tumor; red arrows indicate new bone formation (Zhang, Zhou, etÂ al., <a href="#CIT0147">2019</a>).</p>   </div> </div> <div class="injectablehydrogel" title="sec"><span class="label" tagx="label" title="label">4.2.2.</span><div class="title" tagx="title" title="title">
Injectable hydrogel</div> <p>Injectable drug delivery systems for treating osteolysis mainly include particle and hydrogel. Hydrogel materials incorporated with drugs and NPs have been explored as local delivery systems. The designed injectable hydrogel can solidify with certain environmental conditions. They were supposed to solidify at about 37â€‰Â°C through molecular self-assembly. It is conceivable that injectable hydrogel materials have much weaker mechanical properties than implanted scaffolds and this makes hydrogel inferior to scaffolds as bone substitutes. These materials achieved local delivery through simple local injection, not implant surgery. They were also employed for cancer treatment by many researchers (Norouzi etÂ al., <a href="#CIT0085">2016</a>). For treating osteolysis, pamidronate (Pami)-derivative and Alen-derivative hydrogelators Pami-D and Alen-D were used to form supramolecular hydrogels under acidic conditions. Pami-D and Alen-D inhibited the proliferation and osteoclastogenesis of bone marrow-derived macrophages in a dose-dependent manner <i>inÂ vitro</i> (Tang etÂ al., <a href="#CIT0119">2016</a>). This design enriched the application of BP in the realm of the hydrogel. Injectable hydrogel materials, possessing the property of sustained release, are good drug carriers for treating some diseases with low requirement of the mechanical property.</p> </div> </div> </div> <div class="drugreleaseoptimization" title="sec"><span class="label" tagx="label" title="label">5.</span><div class="title" tagx="title" title="title">
Drug release optimization</div> <div class="responsiverelease" title="sec"><span class="label" tagx="label" title="label">5.1.</span><div class="title" tagx="title" title="title">
Responsive release</div> <p>Stimulus-responsive drug delivery systems based on nanocarriers can be triggered by pH, enzymatic catalysis, magnetic, thermal, ultrasonic, electric, and irradiation stimuli (Liu, Yang, etÂ al., <a href="#CIT0074">2016</a>; Saravanakumar etÂ al., <a href="#CIT0104">2017</a>; Jain etÂ al., <a href="#CIT0054">2018</a>). Smart delivery systems for treating osteolysis can be activated by the osteolytic microenvironment such as low pH, high concentration of calcium, and active redox reaction to release drugs responsively (Karimi etÂ al., <a href="#CIT0057">2016</a>; Tan etÂ al., <a href="#CIT0118">2016</a>; Bai etÂ al., <a href="#CIT0010">2019</a>). Designed pH-sensitive delivery systems release drugs through protonation or deprotonation of groups (carboxylic acid group, amino group) or break of chemical bonds (hydrazone, acetal, cis-Aconityl, Î²-thiopropionate, etc.) in an acidic environment. Aryl boronate group, as an acidâ€"labile linker, was employed to construct pH-sensitive delivery systems. Mingming Wang etÂ al. made polyamidoamine (PAMAM) dendrimer with catechol and PEG ligands modification (Wang, Cai, etÂ al., <a href="#CIT0126">2018</a>). Boronate-catechol linkage was pH-responsive and linked bortezomib (BTZ) to dendrimer for responsive BTZ delivery to low pH. BTZ was released from the polymer less than 5% at pH 7.4 at 12â€‰h but nearly 57% at pH 5.0 at 6â€‰h. PH 5.0 is usually known as the lysosomal pH (pH 4.5) (Wang, Cai, etÂ al., <a href="#CIT0126">2018</a>). A similar design was made by Jianhua Zhu etÂ al. (Zhu etÂ al., <a href="#CIT0153">2018</a>). In a study, Zol-anchored MSNs (DOX@MSNsâ€‰âˆ’â€‰ZOL) loaded DOX and had obvious pH-sensitive DOX release behavior because MSNsâ€‰âˆ’â€‰ZOL did not have enough hydroxyl radicals to create hydrogen bond with the amino group of DOX. DOX@MSNsâ€‰âˆ’â€‰ZOL entered cells through an ATP-dependent pathway and then localized in the lysosome to achieve effective intracellular DOX release (Chen, Boda, etÂ al., <a href="#CIT0013">2018</a>). Chunyan Li etÂ al. fabricated a Ag<sub>2</sub>S QD-based nanosystem (Ald/DOX@Ag<sub>2</sub>S) with surface-anchored ALN and encapsulated DOX (<a href="#F0006">Figure 6(a)</a>). These NPs were deposited in bone tissues and then DOX was released in the tumor site triggered by the acidic tumor microenvironment. The drug release kinetics was exhibited in <a href="#F0006">Figure 6(b)</a>. Ald/DOX@Ag<sub>2</sub>S caused a time and dose-dependent increase in caspase-3 activity (apoptosis assay) and inhibited the osteoclastic differentiation of RAW264.7 cells stimulated by RANKL (Li etÂ al., <a href="#CIT0068">2017</a>). Likewise, redox acted as a trigger in some targeted delivery systems because of the active redox at the osteolytic site. Glutathione (GSH) is an antioxidant and its concentration is 7â€"10 times higher in tumor cells than normal cells (1â€"10â€‰mmol L<sup>âˆ’1</sup>) (Wu etÂ al., <a href="#CIT0137">2004</a>; Aluri etÂ al., <a href="#CIT0005">2009</a>; Wang etÂ al., <a href="#CIT0133">2014</a>). Disulfide bonds can be broken by GSH so that it was utilized by many scientists to fabricate micelles or polymeric NPs in response to the active redox. J.P. Vanderburgh etÂ al. developed aqueous and intravenously injectable micellar NPs to encapsulate GANT58 via a combination of anionic and reversible addition-fragmentation chain transfer (RAFT) polymerization. Poly[(oligo ethylene glycol)<sub>9</sub> methyl ether acrylate]<sub>17</sub> formed the hydrophilic NPs surface while polymer poly(propylene sulfide) formed the hydrophobic core that sequestered GANT58. In response to reactive oxygen species (ROS), poly(propylene sulfide) became hydrophilic and degraded to initiate drug release. In an intratibia breast cancer bone metastasis model, these NPs decreased bone lesion area and lesion number by 49% and 38% respectively, and increased trabecular bone volume (Vanderburgh etÂ al., <a href="#CIT0124">2019</a>). Stimulus-release systems also can be triggered by two or more stimuli. Metal-organic frameworks (MOFs), mainly in a cubic shape, with an average size &amp;lt;100â€‰nm in diameter, were utilized to construct a multi-stimuli â€˜gated scaffold.â€™ The frameworks based on zirconium, remained tightly and controlled release at the normal Ca<sup>2+</sup> concentration, pH, and temperature, but released drugs around/in bone tumor cells with increasing Ca<sup>2+</sup> concentration, decreasing pH, and/or by using thermal therapy. During this process, carboxylatopillar[5]arene played a vital role in regulating the binding between the rings-structure and the stalk-structure (Tan etÂ al., <a href="#CIT0118">2016</a>). Multi-stimuli responsive systems are more sensitive to the osteolytic microenvironment and deliver the drug more rapidly but less specifically. It may be optimized through integration with implantable materials or targeted NPs. Another NPs, DOX@ALN-(HA-PASP)CL, were prepared with pH sensitivity and redox sensitivity. During the synthesis of these NPs, ALN and HA were linked by a hydrazone bond which was responsive to the acidic microenvironment. HA and PASP [poly(aspartic acid)] were cross-linked by a disulfide bond to increase the stability of the NPs. Release kinetics of DOX from DOX@ALN-(HA-PASP)CL was showed in <a href="#F0006">Figure 6(c)</a>. Tumor and bone resorption was inhibited obviously in the research (Zhao etÂ al., <a href="#CIT0150">2017</a>). The responsive delivery embodied the prevention theory. But if osteolysis already happened, stimulus-release aimed to reduce the drug release of miss-targeted NPs to further reduce the side effects and accelerate the drug release in the osteolytic microenvironment.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 6.</span></a></div>   <p>(a) Schematic representation of Ald/DOX@Ag<sub>2</sub>S for bone tumor therapy; (b) Release kinetics of DOX from Ald/DOX@Ag<sub>2</sub>S over time in PBS at pH 5 and 7.4, respectively (Li etÂ al., <a href="#CIT0068">2017</a>). (c) Release kinetics of DOX from DOX@ALN-(HA-PASP)CL, GSH (glutathione), DTT (dithiothreitol) (Zhao etÂ al., <a href="#CIT0150">2017</a>).</p>   </div> </div> <div class="sustainedrelease" title="sec"><span class="label" tagx="label" title="label">5.2.</span><div class="title" tagx="title" title="title">
Sustained release</div> <p>In local delivery systems based on implanted materials, drug loading can be obtained by the following methods: (a). mixing drugs with materials directly before fabrication; (b). entrapping drugs into basic drug carriers (e.g. NPs) and adding this system to implantable materials; (c). immersing scaffold/hydrogel/composite into drugs solution; (d). anchoring drug on the materials (physical adsorption, chemical conjunction); (e). coating the scaffold in a polymer or composite solution (Sarigol-Calamak &amp;amp; Hascicek, <a href="#CIT0105">2018</a>). Drugs can be released from implantable materials in several ways, such as drug diffusion, drug adsorptionâ€"desorption, and materials erosion (Chen, Boda, etÂ al., <a href="#CIT0013">2018</a>). The early-stage release always appears a burst release through diffusion followed by a constant release through materials erosion or further diffusion (Zeng etÂ al., <a href="#CIT0145">2019</a>). Biodegradable materials are degraded by hydrolysis and enzymolysis (Song etÂ al., <a href="#CIT0108">2018</a>). When NPs serve as drug carriers and then are incorporated in implantable materials or modify the materials, special properties of NPs can endow the implantable materials with new merits, such as stimulus-release ability, photothermal property, and more sustained release ability. GG-NPs-ALN system, with ALN-loaded PLGA NPs carried in the matrix of gellan gum, was injectable and delivered ALN intra-bone in a constant manner. The ALN release graphs of NPs-ALN and GG-NPs-ALN are shown in <a href="#F0007">Figure 7</a>. It was obvious that this local release system released drugs more slowly and constantly. GG-NPs-ALN was cytocompatible with osteoblast-like cells but inhibited RANKL mediated osteoclastic differentiation of RAW 264.7 cells significantly <i>inÂ vitro</i> (Posadowska etÂ al., <a href="#CIT0092">2015</a>). Liposomes were often incorporated in hydrogel materials (Ding etÂ al., <a href="#CIT0028">2016</a>; Wu etÂ al., <a href="#CIT0136">2018</a>). Wei Wu etÂ al. designed a local release system (GEM-Lip@Gel) based on hydrogel, in which liposomes blended with methacryloyl (GelMA). Gemcitabine (GEM) was loaded into liposomes for local release to kill osteosarcoma cells. GEM-Lip@Gel (with liposome) had a more constant level than GEM-GelMA (without liposome) in drug release assay and showed the strongest ability to inhibit cancer cells than the control <i>inÂ vitro</i> and <i>inÂ vivo</i> (Wu etÂ al., <a href="#CIT0136">2018</a>). <a href="#t0003">Table 3</a> outlined some local delivery systems of lessening bone destruction and their drug-release characteristics. A sustained release can be realized easily by biodegradable materials like hydrogels. Biodegradable materials release drugs sustainedly through erosion and it is controllable through regulating the matrix ingredient ratio, crosslinking method, or utilizing NPs which encapsulate drugs.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 7.</span></a></div>   <p>ALN release curves from drug-loaded NPs (a) and gellan gum based injectable system (b). Cumulative curves (black squares and lines) as well as doses released from 1â€‰ml of NPs-ALN suspension (1% w/v) or 1â€‰ml of GGâ€"NPs-ALN system during 5Â d intervals (boxes) are shown (Posadowska etÂ al., <a href="#CIT0092">2015</a>).</p>   </div> <div class="table-wrap_UNKNOWN" id="t0003" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 3.</span> <p>Designed local release systems based on nanomaterials or nanotechnology and the released characteristics.</p>  <table frame="hsides" rules="groups"> <colgroup> <col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup>  <thead> <tr> <th align="left">Classification</th> <th align="center">Matrix</th> <th align="center">Fabrication methods</th> <th align="center">Loaded drug</th> <th align="center">Osteogenesis</th> <th align="center">PTT</th> <th align="center">Trigger</th> <th align="center">50% cumulative release time</th> <th align="center">Reference</th> </tr> </thead> <tbody valign="top"> <tr> <td rowspan="8" align="left">Scaffold composite</td> <td align="left">Titanium</td> <td align="left">3D print; slurry foaming method</td> <td align="left">HA NPs</td> <td align="left">Yes</td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">&amp;gt;7Â d</td> <td align="left">(Zhang, Zhou, etÂ al., <a href="#CIT0148">2019</a>)</td> </tr> <tr> <td align="left">Thermoplastic polyurethane (TPU) copolymer with polyvinyl alcohol</td> <td align="left">3D print</td> <td align="left">DOX</td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">âˆ¼1Â d</td> <td align="left">(Ahangar etÂ al., <a href="#CIT0003">2018</a>)</td> </tr> <tr> <td align="left">PCL</td> <td align="left">Solvent casting and particulate leaching technique</td> <td align="left">Dexamethasone</td> <td align="left">Yes</td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">&amp;gt;192â€‰h</td> <td align="left">(PalamÃ etÂ al., <a href="#CIT0089">2017</a>)</td> </tr> <tr> <td align="left">Titania</td> <td align="left">Electrochemical method</td> <td align="left">TRAIL</td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">&amp;gt;4Â d</td> <td align="left">(Kaur etÂ al., <a href="#CIT0058">2016</a>)</td> </tr> <tr> <td align="left">Hydroxyapatite granules and branched copolymer-pamidronate</td> <td align="left">Copolymerization</td> <td align="left">Pamidronate</td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">Bis-MPA-PLLA90-PCL38 â€‰&amp;gt;â€‰20h;bis-MPA -PLLA64-PCL64,bis-MPA -PLLA38-PCL90â€‰&amp;gt;â€‰120h</td> <td align="left">(Oledzka etÂ al., <a href="#CIT0087">2017</a>)</td> </tr> <tr> <td align="left">Gelatin/(Î²-TCP) nanocomposite</td> <td align="left">Cross-linking and self-assemble</td> <td align="left">ZOL</td> <td align="left">yes</td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">(Rahmanian etÂ al., <a href="#CIT0095">2017</a>)</td> </tr> <tr> <td align="left">Hydroxyapatite (HA) and polymethyl methacrylate (PMMA) bone cement</td> <td align="left">Polymerization</td> <td align="left">ZOL</td> <td align="left">Yes</td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">(Koto etÂ al., <a href="#CIT0061">2017</a>)</td> </tr> <tr> <td align="left">CS</td> <td align="left">Freeze-drying</td> <td align="left">Â </td> <td align="left">Yes</td> <td align="left">Yes</td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">(Zhao etÂ al., <a href="#CIT0149">2020</a>)</td> </tr> <tr> <td rowspan="4" align="left">Hydrogel</td> <td align="left">Pluronic</td> <td align="left">Cold method</td> <td align="left">Bleomycin A6</td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">âˆ¼8â€‰h</td> <td align="left">(Ding etÂ al., <a href="#CIT0028">2016</a>)</td> </tr> <tr> <td align="left">Gelatin methacryloyl</td> <td align="left"><i>In-situ</i> photocrosslinkable</td> <td align="left">Gemcitabine</td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">Â </td> <td align="left"><div class="âˆ¼12â€‰h_UNKNOWN" /></td> <td align="left">(Wu etÂ al., <a href="#CIT0136">2018</a>)</td> </tr> <tr> <td align="left">Gellan gum</td> <td align="left">Cross-linking and reassemble</td> <td align="left">ALN</td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">&amp;gt;25Â d</td> <td align="left">(Posadowska etÂ al., <a href="#CIT0092">2015</a>)</td> </tr> <tr> <td align="left">Pami-D; Alen-D</td> <td align="left">Self-assemble</td> <td align="left">Pami-D; Alen-D</td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">Â </td> <td align="left">(Tang etÂ al., <a href="#CIT0119">2016</a>)</td> </tr> </tbody> </table> </div> </div> </div> <div class="theprospect" title="sec"><span class="label" tagx="label" title="label">6.</span><div class="title" tagx="title" title="title">
The prospect</div> <div class="multifunctionalnanomaterials" title="sec"><span class="label" tagx="label" title="label">6.1.</span><div class="title" tagx="title" title="title">
Multifunctional nanomaterials</div> <p>The optimization in this review does not merely focus on drug distribution and release manner but also emphasizes the design of multifunctional materials. Utilizing nanotechnology to realize inhibiting cancer cells and osteoclasts simultaneously is a great optimization and improvable. When metastatic bone destruction occurs, it is not enough to anti-cancer and anti bone resorption, promoting bone regeneration is also important to improve the quality of life. In tissue engineering and regenerative medicine, many implantable biomaterials have been designed with good biocompatibility and osteoconductive ability to promote bone tissue regeneration (Sarigol-Calamak &amp;amp; Hascicek, <a href="#CIT0105">2018</a>; Martin &amp;amp; Bettencourt, <a href="#CIT0081">2018</a>). Calcium phosphate (Lee etÂ al., <a href="#CIT0064">2016</a>), CS (Kozusko etÂ al., <a href="#CIT0062">2018</a>), collagen (Cruz-Neves etÂ al., <a href="#CIT0024">2017</a>), hyaluronic acid, nHA (Cruz-Neves etÂ al., <a href="#CIT0024">2017</a>), polymers (Olthof etÂ al., <a href="#CIT0088">2018</a>; Sarigol-Calamak &amp;amp; Hascicek, <a href="#CIT0105">2018</a>), metal and some composites (Newman &amp;amp; Benoit, <a href="#CIT0083">2016</a>) were often used to fabricate bionic scaffolds with osteogenesis drugs, factors or even cells carried on, like bone morphogenetic protein-2 (BMP-2) (Holzapfel etÂ al., <a href="#CIT0049">2016</a>; Lee etÂ al., <a href="#CIT0064">2016</a>; Martin &amp;amp; Bettencourt, <a href="#CIT0081">2018</a>; Olthof etÂ al., <a href="#CIT0088">2018</a>). These implanted bone tissue engineering or bone regeneration materials can be explored as multifunctional materials to carry anti-osteolysis drugs or anti-osteolysis drug delivery systems. Multifunctional materials also are characterized by multi drugs and multi delivery systems. The integration of different drugs and different systems (target delivery systems, PTT systems, local delivery systems) can be realized by tactfully designed nanomaterials and novel fabrication nanotechnology. During the treatment of osteolysis, reducing bone pain is another therapy goal. Designed materials should also be tested for their bone pain alleviating ability, such as mechanical allodynia and thermal hyperalgesia test on cancer metastasis model (De Felice etÂ al., <a href="#CIT0026">2016</a>; Wei etÂ al., <a href="#CIT0135">2017</a>; Zhou, Chen, etÂ al., <a href="#CIT0151">2017</a>).</p> </div> <div class="genetherapy" title="sec"><span class="label" tagx="label" title="label">6.2.</span><div class="title" tagx="title" title="title">
Gene therapy</div> <p>Gene therapy aims at regulating cellsâ€™ apoptosis and function at the level of genes to treat disease. Most cancer-related gene therapy introduced exogenous DNA segments or delivered siRNA or miRNA into target cells to regulate DNA expression (Fitzgerald etÂ al., <a href="#CIT0036">2016</a>; Wang, Yu, etÂ al., <a href="#CIT0134">2016</a>; Lima etÂ al., <a href="#CIT0069">2019</a>). Till November 2017, almost 2600 gene therapy clinical trials had been completed and about 85% of these trials used a virus as vectors or naked/plasmid DNA (Ginn etÂ al., <a href="#CIT0044">2018</a>). However, The clinic applications are limited because of the drawbacks of nucleic acids. The free nucleic acid in blood could be degraded by various cells (reticuloendothelial system, mononuclear phagocyte system) and biomolecules (nucleases). The size of plasmid DNA could hinder it into cells (Zhou, Liu, etÂ al., <a href="#CIT0152">2017</a>). Several non-viral vectors were fabricated to deliver nucleic acid, including cationic polymers like polylysine (PLL), poly(ethyleneimine) (PEI), PAMAM, PEG, CS, cationic lipids (Chen, Yue, etÂ al., <a href="#CIT0019">2018</a>), inorganic NPs (gold, silica, iron oxide and quantum dot) (Zhou, Liu, etÂ al., <a href="#CIT0152">2017</a>). In many types of research, gene therapy cooperated with PTT to anti-cancer relying on nano delivery systems (Kim etÂ al., <a href="#CIT0060">2016</a>; Wang, Yu, etÂ al., <a href="#CIT0134">2016</a>; Chu etÂ al., <a href="#CIT0022">2019</a>). Knockdown of BMPR1a in breast cancer cells through Adenovirus-mediated RNA interference was reported to suppress the production of RANKL via p38 pathway and inhibit cancer-induced osteoclast genesis (Liu etÂ al., <a href="#CIT0075">2018</a>). However, few delivery systems of optimizing gene delivery to stop the â€˜vicious circleâ€™ were available. Actually, the aforementioned nanomaterials or nanotechnology can be applied to optimize the relevant DNA/RNA delivery to hinder osteolysis.</p> <p>Exosomes are a hot topic recently. Exosomes are lipid bilayer vesicles containing miRNA and protein. They are produced and excreted from cells to regulate cellsâ€™ action and are also explored as drug carriers (Ha etÂ al., <a href="#CIT0046">2016</a>; Bellavia etÂ al., <a href="#CIT0011">2018</a>).</p> <p>In osteolysis, some miRNAs play a very important role in regulating bone destruction. MiR-31, miR-33a, miR-34a, miR-133a, miR-141, miR-155, miR-190, miR-192, miR-219, and miR-223 were reported to be capable of influencing osteoclast differentiation in bone metastasis (Ell etÂ al., <a href="#CIT0033">2013</a>; Kagiya, <a href="#CIT0056">2015</a>). A hydrogel-embedded, gold-NPs-based delivery vehicle provided efficient local, selective, and sustained release of miR-96/miR-182, markedly suppressed metastasis in a breast cancer mouse model (Gilam etÂ al., <a href="#CIT0043">2016</a>). Implantable nanomaterials and targeted NPs may provide new ways for applying miRNA or exosome to cure osteolysis.</p> </div> </div> </div> <div class="back" title="back"> <div class="COI-statement" title="COI-statement"> <div class="title" tagx="title" title="title">
Disclosure statement</div> <p>No potential conflict of interest was reported by the author(s).</p> </div> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
References</div> <li tag="ref"><a name="CIT0001" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Abadeer</span><span class="given-names" tagx="given-names" title="given-names">NS</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Murphy</span><span class="given-names" tagx="given-names" title="given-names">CJ.</span></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Recent progress in cancer thermal therapy using gold nanoparticles</span>. <span class="source" tagx="source" title="source">J Phys Chem C</span><span class="volume" tagx="volume" title="volume">120</span>:<span class="fpage" tagx="fpage" title="fpage">4691</span>â€"<span class="lpage" tagx="lpage" title="lpage">716</span>.</span></li> <li tag="ref"><a name="CIT0002" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Adjei</span><span class="given-names" tagx="given-names" title="given-names">IM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sharma</span><span class="given-names" tagx="given-names" title="given-names">B</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Peetla</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Inhibition of bone loss with surface-modulated, drug-loaded nanoparticles in an intraosseous model of prostate cancer</span>. <span class="source" tagx="source" title="source">J Controlled Release</span><span class="volume" tagx="volume" title="volume">232</span>:<span class="fpage" tagx="fpage" title="fpage">83</span>â€"<span class="lpage" tagx="lpage" title="lpage">92</span>.</span></li> <li tag="ref"><a name="CIT0003" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ahangar</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Akoury</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Luna</span><span class="given-names" tagx="given-names" title="given-names">ASRG</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2018</span>). <span class="mixed-article-title" title="mixed-article-title">Nanoporous 3D-printed scaffolds for local doxorubicin delivery in bone metastases secondary to prostate cancer</span>. <span class="source" tagx="source" title="source">Materials</span><span class="volume" tagx="volume" title="volume">11</span>:<span class="fpage" tagx="fpage" title="fpage">1485</span>.</span></li> <li tag="ref"><a name="CIT0004" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ahangar</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Aziz</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rosenzweig</span><span class="given-names" tagx="given-names" title="given-names">DH</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title">Advances in personalized treatment of metastatic spine disease</span>. <span class="source" tagx="source" title="source">Ann Transl Med</span><span class="volume" tagx="volume" title="volume">7</span>:<span class="fpage" tagx="fpage" title="fpage">223</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31297388">31297388</a></span></span></li> <li tag="ref"><a name="CIT0005" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Aluri</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Janib</span><span class="given-names" tagx="given-names" title="given-names">SM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mackay</span><span class="given-names" tagx="given-names" title="given-names">JA.</span></span></span> (<span class="year" tagx="year" title="year">2009</span>). <span class="mixed-article-title" title="mixed-article-title">Environmentally responsive peptides as anticancer drug carriers</span>. <span class="source" tagx="source" title="source">Adv Drug Deliv Rev</span><span class="volume" tagx="volume" title="volume">61</span>:<span class="fpage" tagx="fpage" title="fpage">940</span>â€"<span class="lpage" tagx="lpage" title="lpage">52</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19628014">19628014</a></span></span></li> <li tag="ref"><a name="CIT0006" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">An</span><span class="given-names" tagx="given-names" title="given-names">SB</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Han</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">YH</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2018</span>). <span class="mixed-article-title" title="mixed-article-title">Curcumin inhibits polyethylene-induced osteolysis via repressing NF-ÎºB signaling pathway activation</span>. <span class="source" tagx="source" title="source">Cell Physiol Biochem</span><span class="volume" tagx="volume" title="volume">50</span>:<span class="fpage" tagx="fpage" title="fpage">1100</span>â€"<span class="lpage" tagx="lpage" title="lpage">12</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30355954">30355954</a></span></span></li> <li tag="ref"><a name="CIT0007" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Andrade</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fornetti</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">RON kinase: a target for treatment of cancer-induced bone destruction and osteoporosis</span>. <span class="source" tagx="source" title="source">Sci Transl Med</span><span class="volume" tagx="volume" title="volume">9</span>:<span class="fpage" tagx="fpage" title="fpage">eaai9338</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28123075">28123075</a></span></span></li> <li tag="ref"><a name="CIT0008" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Assaraf</span><span class="given-names" tagx="given-names" title="given-names">YG</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Leamon</span><span class="given-names" tagx="given-names" title="given-names">CP</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Reddy</span><span class="given-names" tagx="given-names" title="given-names">JA.</span></span></span> (<span class="year" tagx="year" title="year">2014</span>). <span class="mixed-article-title" title="mixed-article-title">The folate receptor as a rational therapeutic target for personalized cancer treatment</span>. <span class="source" tagx="source" title="source">Drug Resist Updat</span><span class="volume" tagx="volume" title="volume">17</span>:<span class="fpage" tagx="fpage" title="fpage">89</span>â€"<span class="lpage" tagx="lpage" title="lpage">95</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25457975">25457975</a></span></span></li> <li tag="ref"><a name="CIT0009" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Au</span><span class="given-names" tagx="given-names" title="given-names">KM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Satterlee</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Min</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Folate-targeted pH-responsive calcium zoledronate nanoscale metal-organic frameworks: turning a bone antiresorptive agent into an anticancer therapeutic</span>. <span class="source" tagx="source" title="source">Biomaterials</span><span class="volume" tagx="volume" title="volume">82</span>:<span class="fpage" tagx="fpage" title="fpage">178</span>â€"<span class="lpage" tagx="lpage" title="lpage">93</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26763733">26763733</a></span></span></li> <li tag="ref"><a name="CIT0010" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bai</span><span class="given-names" tagx="given-names" title="given-names">S-b</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">D-z</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cheng</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title">Osteoclasts and tumor cells dual targeting nanoparticle to treat bone metastases of lung cancer</span>. <span class="source" tagx="source" title="source">Nanomed-Nanotechnol Biol Med</span><span class="volume" tagx="volume" title="volume">21</span>:<span class="fpage" tagx="fpage" title="fpage">102054</span>.</span></li> <li tag="ref"><a name="CIT0011" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bellavia</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Raimondi</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Costa</span><span class="given-names" tagx="given-names" title="given-names">V</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2018</span>). <span class="mixed-article-title" title="mixed-article-title">Engineered exosomes: a new promise for the management of musculoskeletal diseases</span>. <span class="source" tagx="source" title="source">Biochim Biophys Acta Gen Subj</span><span class="volume" tagx="volume" title="volume">1862</span>:<span class="fpage" tagx="fpage" title="fpage">1893</span>â€"<span class="lpage" tagx="lpage" title="lpage">901</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29885361">29885361</a></span></span></li> <li tag="ref"><a name="CIT0012" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chang</span><span class="given-names" tagx="given-names" title="given-names">Q</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Geng</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">DOPA-based paclitaxel-loaded liposomes with modifications of transferrin and alendronate for bone and myeloma targeting</span>. <span class="source" tagx="source" title="source">Drug Deliv</span><span class="volume" tagx="volume" title="volume">23</span>:<span class="fpage" tagx="fpage" title="fpage">3629</span>â€"<span class="lpage" tagx="lpage" title="lpage">38</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27749106">27749106</a></span></span></li> <li tag="ref"><a name="CIT0013" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Boda</span><span class="given-names" tagx="given-names" title="given-names">SK</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Batra</span><span class="given-names" tagx="given-names" title="given-names">SK</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2018</span>). <span class="mixed-article-title" title="mixed-article-title">Emerging roles of electrospun nanofibers in cancer research</span>. <span class="source" tagx="source" title="source">Adv Healthcare Mater</span><span class="volume" tagx="volume" title="volume">7</span>:<span class="fpage" tagx="fpage" title="fpage">1701024</span>.</span></li> <li tag="ref"><a name="CIT0014" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">He</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jiang</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title">In vivo SELEX of bone targeting aptamer in prostate cancer bone metastasis model</span>. <span class="source" tagx="source" title="source">Int J Nanomedicine</span><span class="volume" tagx="volume" title="volume">14</span>:<span class="fpage" tagx="fpage" title="fpage">149</span>â€"<span class="lpage" tagx="lpage" title="lpage">59</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30613143">30613143</a></span></span></li> <li tag="ref"><a name="CIT0015" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">SH</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">TI</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chuang</span><span class="given-names" tagx="given-names" title="given-names">CL</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2020</span>). <span class="mixed-article-title" title="mixed-article-title">Alendronate/folic acid-decorated polymeric nanoparticles for hierarchically targetable chemotherapy against bone metastatic breast cancer</span>. <span class="source" tagx="source" title="source">J Mater Chem B</span><span class="volume" tagx="volume" title="volume">8</span>:<span class="fpage" tagx="fpage" title="fpage">3789</span>â€"<span class="lpage" tagx="lpage" title="lpage">800</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32150202">32150202</a></span></span></li> <li tag="ref"><a name="CIT0016" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">JQ</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ning</span><span class="given-names" tagx="given-names" title="given-names">CY</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">ZN</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title">Nanomaterials as photothermal therapeutic agents</span>. <span class="source" tagx="source" title="source">Prog Mater Sci</span><span class="volume" tagx="volume" title="volume">99</span>:<span class="fpage" tagx="fpage" title="fpage">1</span>â€"<span class="lpage" tagx="lpage" title="lpage">26</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30568319">30568319</a></span></span></li> <li tag="ref"><a name="CIT0017" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">XH</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pei</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Peng</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2018</span>). <span class="mixed-article-title" title="mixed-article-title">Exploring the molecular mechanism associated with breast cancer bone metastasis using bioinformatic analysis and microarray genetic interaction network</span>. <span class="source" tagx="source" title="source">Medicine</span><span class="volume" tagx="volume" title="volume">97</span>:<span class="fpage" tagx="fpage" title="fpage">e12032</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30212931">30212931</a></span></span></li> <li tag="ref"><a name="CIT0018" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gu</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title">Bioinspired and biomimetic nanomedicines</span>. <span class="source" tagx="source" title="source">Acc Chem Res</span><span class="volume" tagx="volume" title="volume">52</span>:<span class="fpage" tagx="fpage" title="fpage">1255</span>â€"<span class="lpage" tagx="lpage" title="lpage">64</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30977635">30977635</a></span></span></li> <li tag="ref"><a name="CIT0019" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yue</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lei</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2018</span>). <span class="mixed-article-title" title="mixed-article-title">Promoter-operating targeted expression of gene therapy in cancer: current stage and prospect</span>. <span class="source" tagx="source" title="source">Mol Ther Nucleic Acids</span><span class="volume" tagx="volume" title="volume">11</span>:<span class="fpage" tagx="fpage" title="fpage">508</span>â€"<span class="lpage" tagx="lpage" title="lpage">14</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29858085">29858085</a></span></span></li> <li tag="ref"><a name="CIT0020" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chew</span><span class="given-names" tagx="given-names" title="given-names">SA</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Danti</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">Biomaterial-based implantable devices for cancer therapy</span>. <span class="source" tagx="source" title="source">Adv Healthcare Mater</span><span class="volume" tagx="volume" title="volume">6</span>:<span class="fpage" tagx="fpage" title="fpage">1600766</span>.</span></li> <li tag="ref"><a name="CIT0021" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chu</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">Calcium phosphate nanoparticles functionalized with alendronate-conjugated polyethylene glycol (PEG) for the treatment of bone metastasis</span>. <span class="source" tagx="source" title="source">Int J Pharm</span><span class="volume" tagx="volume" title="volume">516</span>:<span class="fpage" tagx="fpage" title="fpage">352</span>â€"<span class="lpage" tagx="lpage" title="lpage">63</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27887884">27887884</a></span></span></li> <li tag="ref"><a name="CIT0022" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chu</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ren</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title">Zinc(II)-dipicolylamine coordination nanotheranostics: toward synergistic nanomedicine by combined photo/gene therapy</span>. <span class="source" tagx="source" title="source">Angew Chem Int Ed Engl</span><span class="volume" tagx="volume" title="volume">58</span>:<span class="fpage" tagx="fpage" title="fpage">269</span>â€"<span class="lpage" tagx="lpage" title="lpage">72</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30421488">30421488</a></span></span></li> <li tag="ref"><a name="CIT0023" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Croucher</span><span class="given-names" tagx="given-names" title="given-names">PI</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">McDonald</span><span class="given-names" tagx="given-names" title="given-names">MM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Martin</span><span class="given-names" tagx="given-names" title="given-names">TJ.</span></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Bone metastasis: the importance of the neighbourhood</span>. <span class="source" tagx="source" title="source">Nat Rev Cancer</span><span class="volume" tagx="volume" title="volume">16</span>:<span class="fpage" tagx="fpage" title="fpage">373</span>â€"<span class="lpage" tagx="lpage" title="lpage">86</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27220481">27220481</a></span></span></li> <li tag="ref"><a name="CIT0024" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cruz-Neves</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ribeiro</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Graca</span><span class="given-names" tagx="given-names" title="given-names">I</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">Behavior of prostate cancer cells in a nanohydroxyapatite/collagen bone scaffold</span>. <span class="source" tagx="source" title="source">J Biomed Mater Res A</span><span class="volume" tagx="volume" title="volume">105</span>:<span class="fpage" tagx="fpage" title="fpage">2035</span>â€"<span class="lpage" tagx="lpage" title="lpage">46</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28371333">28371333</a></span></span></li> <li tag="ref"><a name="CIT0025" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Danaei</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dehghankhold</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ataei</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2018</span>). <span class="mixed-article-title" title="mixed-article-title">Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems</span>. <span class="source" tagx="source" title="source">Pharmaceutics</span><span class="volume" tagx="volume" title="volume">10</span>:<span class="fpage" tagx="fpage" title="fpage">57</span>.</span></li> <li tag="ref"><a name="CIT0026" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">De Felice</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lambert</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Holen</span><span class="given-names" tagx="given-names" title="given-names">I</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Effects of Src-kinase inhibition in cancer-induced bone pain</span>. <span class="source" tagx="source" title="source">Mol Pain</span><span class="volume" tagx="volume" title="volume">12</span>:<span class="fpage" tagx="fpage" title="fpage">174480691664372</span>.</span></li> <li tag="ref"><a name="CIT0027" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">de Miguel</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Noiray</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Surpateanu</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2014</span>). <span class="mixed-article-title" title="mixed-article-title">Poly(Î³-benzyl-L-glutamate)-PEG-alendronate multivalent nanoparticles for bone targeting</span>. <span class="source" tagx="source" title="source">Int J Pharm</span><span class="volume" tagx="volume" title="volume">460</span>:<span class="fpage" tagx="fpage" title="fpage">73</span>â€"<span class="lpage" tagx="lpage" title="lpage">82</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/24211357">24211357</a></span></span></li> <li tag="ref"><a name="CIT0028" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ding</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hou</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Bleomycin A6-loaded anionic liposomes with in situ gel as a new antitumoral drug delivery system</span>. <span class="source" tagx="source" title="source">Drug Deliv</span><span class="volume" tagx="volume" title="volume">23</span>:<span class="fpage" tagx="fpage" title="fpage">88</span>â€"<span class="lpage" tagx="lpage" title="lpage">94</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/24845479">24845479</a></span></span></li> <li tag="ref"><a name="CIT0029" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dlamini</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mukaya</span><span class="given-names" tagx="given-names" title="given-names">HE</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Van Zyl</span><span class="given-names" tagx="given-names" title="given-names">RL</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title">Synthesis, characterization, kinetic drug release and anticancer activity of bisphosphonates multi-walled carbon nanotube conjugates</span>. <span class="source" tagx="source" title="source">Mater Sci Eng C-Mater Biol Appl</span><span class="volume" tagx="volume" title="volume">104</span>:<span class="fpage" tagx="fpage" title="fpage">109967</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31499981">31499981</a></span></span></li> <li tag="ref"><a name="CIT0030" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Do</span><span class="given-names" tagx="given-names" title="given-names">AV</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Khorsand</span><span class="given-names" tagx="given-names" title="given-names">B</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Geary</span><span class="given-names" tagx="given-names" title="given-names">SM</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2015</span>). <span class="mixed-article-title" title="mixed-article-title">3D printing of scaffolds for tissue regeneration applications</span>. <span class="source" tagx="source" title="source">Adv Healthc Mater</span><span class="volume" tagx="volume" title="volume">4</span>:<span class="fpage" tagx="fpage" title="fpage">1742</span>â€"<span class="lpage" tagx="lpage" title="lpage">62</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26097108">26097108</a></span></span></li> <li tag="ref"><a name="CIT0031" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dosio</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Arpicco</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Stella</span><span class="given-names" tagx="given-names" title="given-names">B</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Hyaluronic acid for anticancer drug and nucleic acid delivery</span>. <span class="source" tagx="source" title="source">Adv Drug Deliv Rev</span><span class="volume" tagx="volume" title="volume">97</span>:<span class="fpage" tagx="fpage" title="fpage">204</span>â€"<span class="lpage" tagx="lpage" title="lpage">36</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26592477">26592477</a></span></span></li> <li tag="ref"><a name="CIT0032" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Duong</span><span class="given-names" tagx="given-names" title="given-names">LT</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wesolowski</span><span class="given-names" tagx="given-names" title="given-names">GA</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Leung</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2014</span>). <span class="mixed-article-title" title="mixed-article-title">Efficacy of a cathepsin K inhibitor in a preclinical model for prevention and treatment of breast cancer bone metastasis</span>. <span class="source" tagx="source" title="source">Mol Cancer Ther</span><span class="volume" tagx="volume" title="volume">13</span>:<span class="fpage" tagx="fpage" title="fpage">2898</span>â€"<span class="lpage" tagx="lpage" title="lpage">909</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25249554">25249554</a></span></span></li> <li tag="ref"><a name="CIT0033" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ell</span><span class="given-names" tagx="given-names" title="given-names">B</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mercatali</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ibrahim</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2013</span>). <span class="mixed-article-title" title="mixed-article-title">Tumor-induced osteoclast miRNA changes as regulators and biomarkers of osteolytic bone metastasis</span>. <span class="source" tagx="source" title="source">Cancer Cell</span><span class="volume" tagx="volume" title="volume">24</span>:<span class="fpage" tagx="fpage" title="fpage">542</span>â€"<span class="lpage" tagx="lpage" title="lpage">56</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/24135284">24135284</a></span></span></li> <li tag="ref"><a name="CIT0034" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Feng</span><span class="given-names" tagx="given-names" title="given-names">M-X</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hong</span><span class="given-names" tagx="given-names" title="given-names">J-X</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Q</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Dihydroartemisinin prevents breast cancer-induced osteolysis via inhibiting both breast caner cells and osteoclasts</span>. <span class="source" tagx="source" title="source">Sci Rep</span><span class="volume" tagx="volume" title="volume">6</span>:<span class="fpage" tagx="fpage" title="fpage">19074</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26743690">26743690</a></span></span></li> <li tag="ref"><a name="CIT0035" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Feng</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">Z-X</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title">Engineering of bone- and CD44-dual-targeting redox-sensitive liposomes for the treatment of orthotopic osteosarcoma</span>. <span class="source" tagx="source" title="source">ACS Appl Mater Interfaces</span><span class="volume" tagx="volume" title="volume">11</span>:<span class="fpage" tagx="fpage" title="fpage">7357</span>â€"<span class="lpage" tagx="lpage" title="lpage">68</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30682240">30682240</a></span></span></li> <li tag="ref"><a name="CIT0036" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fitzgerald</span><span class="given-names" tagx="given-names" title="given-names">KA</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guo</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Raftery</span><span class="given-names" tagx="given-names" title="given-names">RM</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Nanoparticle-mediated siRNA delivery assessed in a 3D co-culture model simulating prostate cancer bone metastasis</span>. <span class="source" tagx="source" title="source">Int J Pharm</span><span class="volume" tagx="volume" title="volume">511</span>:<span class="fpage" tagx="fpage" title="fpage">1058</span>â€"<span class="lpage" tagx="lpage" title="lpage">69</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27492023">27492023</a></span></span></li> <li tag="ref"><a name="CIT0037" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Forte</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Torricelli</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Boanini</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">Quercetin and alendronate multi-functionalized materials as tools to hinder oxidative stress damage</span>. <span class="source" tagx="source" title="source">J Biomed Mater Res A</span><span class="volume" tagx="volume" title="volume">105</span>:<span class="fpage" tagx="fpage" title="fpage">3293</span>â€"<span class="lpage" tagx="lpage" title="lpage">303</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28865182">28865182</a></span></span></li> <li tag="ref"><a name="CIT0038" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Futakuchi</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fukamachi</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Suzui</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Heterogeneity of tumor cells in the bone microenvironment: mechanisms and therapeutic targets for bone metastasis of prostate or breast cancer</span>. <span class="source" tagx="source" title="source">Adv Drug Deliv Rev</span><span class="volume" tagx="volume" title="volume">99</span>:<span class="fpage" tagx="fpage" title="fpage">206</span>â€"<span class="lpage" tagx="lpage" title="lpage">11</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26656603">26656603</a></span></span></li> <li tag="ref"><a name="CIT0039" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gdowski</span><span class="given-names" tagx="given-names" title="given-names">AS</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lampe</span><span class="given-names" tagx="given-names" title="given-names">JB</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lin</span><span class="given-names" tagx="given-names" title="given-names">VJT</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title">Bioinspired nanoparticles engineered for enhanced delivery to the bone</span>. <span class="source" tagx="source" title="source">ACS Appl Nano Mater</span><span class="volume" tagx="volume" title="volume">2</span>:<span class="fpage" tagx="fpage" title="fpage">6249</span>â€"<span class="lpage" tagx="lpage" title="lpage">57</span>.</span></li> <li tag="ref"><a name="CIT0040" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gdowski</span><span class="given-names" tagx="given-names" title="given-names">AS</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ranjan</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sarker</span><span class="given-names" tagx="given-names" title="given-names">MR</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">Bone-targeted cabazitaxel nanoparticles for metastatic prostate cancer skeletal lesions and pain</span>. <span class="source" tagx="source" title="source">Nanomedicine</span><span class="volume" tagx="volume" title="volume">12</span>:<span class="fpage" tagx="fpage" title="fpage">2083</span>â€"<span class="lpage" tagx="lpage" title="lpage">95</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28805551">28805551</a></span></span></li> <li tag="ref"><a name="CIT0041" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ge</span><span class="given-names" tagx="given-names" title="given-names">YW</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Feng</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">XL</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2020</span>). <span class="mixed-article-title" title="mixed-article-title">Quercetin inhibits macrophage polarization through the p-38Î±/Î² signalling pathway and regulates OPG/RANKL balance in a mouse skull model</span>. <span class="source" tagx="source" title="source">J Cell Mol Med</span><span class="volume" tagx="volume" title="volume">24</span>:<span class="fpage" tagx="fpage" title="fpage">3203</span>â€"<span class="lpage" tagx="lpage" title="lpage">16</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32053272">32053272</a></span></span></li> <li tag="ref"><a name="CIT0042" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">George</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shah</span><span class="given-names" tagx="given-names" title="given-names">PA</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shrivastav</span><span class="given-names" tagx="given-names" title="given-names">PS.</span></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title">Natural biodegradable polymers based nano-formulations for drug delivery: a review</span>. <span class="source" tagx="source" title="source">Int J Pharm</span><span class="volume" tagx="volume" title="volume">561</span>:<span class="fpage" tagx="fpage" title="fpage">244</span>â€"<span class="lpage" tagx="lpage" title="lpage">64</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30851391">30851391</a></span></span></li> <li tag="ref"><a name="CIT0043" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gilam</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Conde</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Weissglas-Volkov</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Local microRNA delivery targets palladin and prevents metastatic breast cancer</span>. <span class="source" tagx="source" title="source">Nat Commun</span><span class="volume" tagx="volume" title="volume">7</span>:<span class="fpage" tagx="fpage" title="fpage">12868</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27641360">27641360</a></span></span></li> <li tag="ref"><a name="CIT0044" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ginn</span><span class="given-names" tagx="given-names" title="given-names">SL</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Amaya</span><span class="given-names" tagx="given-names" title="given-names">AK</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Alexander</span><span class="given-names" tagx="given-names" title="given-names">IE</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2018</span>). <span class="mixed-article-title" title="mixed-article-title">Gene therapy clinical trials worldwide to 2017: an update</span>. <span class="source" tagx="source" title="source">J Gene Med</span><span class="volume" tagx="volume" title="volume">20</span>:<span class="fpage" tagx="fpage" title="fpage">e3015</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29575374">29575374</a></span></span></li> <li tag="ref"><a name="CIT0045" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gul</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sendur</span><span class="given-names" tagx="given-names" title="given-names">MAN</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Aksoy</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">A comprehensive review of denosumab for bone metastasis in patients with solid tumors</span>. <span class="source" tagx="source" title="source">Curr Med Res Opin</span><span class="volume" tagx="volume" title="volume">32</span>:<span class="fpage" tagx="fpage" title="fpage">133</span>â€"<span class="lpage" tagx="lpage" title="lpage">45</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26451465">26451465</a></span></span></li> <li tag="ref"><a name="CIT0046" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ha</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">NN</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nadithe</span><span class="given-names" tagx="given-names" title="given-names">V.</span></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges</span>. <span class="source" tagx="source" title="source">Acta Pharm Sin B</span><span class="volume" tagx="volume" title="volume">6</span>:<span class="fpage" tagx="fpage" title="fpage">287</span>â€"<span class="lpage" tagx="lpage" title="lpage">96</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27471669">27471669</a></span></span></li> <li tag="ref"><a name="CIT0047" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hatami</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nagesh</span><span class="given-names" tagx="given-names" title="given-names">PKB</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chowdhury</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title">Development of zoledronic acid-based nanoassemblies for bone-targeted anticancer therapy</span>. <span class="source" tagx="source" title="source">ACS Biomater Sci Eng</span><span class="volume" tagx="volume" title="volume">5</span>:<span class="fpage" tagx="fpage" title="fpage">2343</span>â€"<span class="lpage" tagx="lpage" title="lpage">54</span>.</span></li> <li tag="ref"><a name="CIT0048" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hirano</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Iwasaki</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">Bone-specific poly(ethylene sodium phosphate)-bearing biodegradable nanoparticles</span>. <span class="source" tagx="source" title="source">Colloids Surf B Biointerfaces</span><span class="volume" tagx="volume" title="volume">153</span>:<span class="fpage" tagx="fpage" title="fpage">104</span>â€"<span class="lpage" tagx="lpage" title="lpage">10</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28231498">28231498</a></span></span></li> <li tag="ref"><a name="CIT0049" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Holzapfel</span><span class="given-names" tagx="given-names" title="given-names">BM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wagner</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Martine</span><span class="given-names" tagx="given-names" title="given-names">LC</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Tissue engineering and regenerative medicine in musculoskeletal oncology</span>. <span class="source" tagx="source" title="source">Cancer Metastasis Rev</span><span class="volume" tagx="volume" title="volume">35</span>:<span class="fpage" tagx="fpage" title="fpage">475</span>â€"<span class="lpage" tagx="lpage" title="lpage">87</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27566370">27566370</a></span></span></li> <li tag="ref"><a name="CIT0050" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Horne</span><span class="given-names" tagx="given-names" title="given-names">AM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mihov</span><span class="given-names" tagx="given-names" title="given-names">B</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Reid</span><span class="given-names" tagx="given-names" title="given-names">IR.</span></span></span> (<span class="year" tagx="year" title="year">2018</span>). <span class="mixed-article-title" title="mixed-article-title">Bone loss after romosozumab/denosumab: effects of bisphosphonates</span>. <span class="source" tagx="source" title="source">Calcif Tissue Int</span><span class="volume" tagx="volume" title="volume">103</span>:<span class="fpage" tagx="fpage" title="fpage">55</span>â€"<span class="lpage" tagx="lpage" title="lpage">61</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29445836">29445836</a></span></span></li> <li tag="ref"><a name="CIT0051" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hsieh</span><span class="given-names" tagx="given-names" title="given-names">C-J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kuo</span><span class="given-names" tagx="given-names" title="given-names">P-L</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hou</span><span class="given-names" tagx="given-names" title="given-names">M-F</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2015</span>). <span class="mixed-article-title" title="mixed-article-title">Wedelolactone inhibits breast cancer-induced osteoclastogenesis by decreasing Akt/mTOR signaling</span>. <span class="source" tagx="source" title="source">Int J Oncol</span><span class="volume" tagx="volume" title="volume">46</span>:<span class="fpage" tagx="fpage" title="fpage">555</span>â€"<span class="lpage" tagx="lpage" title="lpage">62</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25421824">25421824</a></span></span></li> <li tag="ref"><a name="CIT0052" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">K-f</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kong</span><span class="given-names" tagx="given-names" title="given-names">X-y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhong</span><span class="given-names" tagx="given-names" title="given-names">M-c</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">Brucine inhibits bone metastasis of breast cancer cells by suppressing jagged1/notch1 signaling pathways</span>. <span class="source" tagx="source" title="source">Chin J Integr Med</span><span class="volume" tagx="volume" title="volume">23</span>:<span class="fpage" tagx="fpage" title="fpage">110</span>â€"<span class="lpage" tagx="lpage" title="lpage">16</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28035539">28035539</a></span></span></li> <li tag="ref"><a name="CIT0053" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Irelli</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cocciolone</span><span class="given-names" tagx="given-names" title="given-names">V</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cannita</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Bone targeted therapy for preventing skeletal-related events in metastatic breast cancer</span>. <span class="source" tagx="source" title="source">Bone</span><span class="volume" tagx="volume" title="volume">87</span>:<span class="fpage" tagx="fpage" title="fpage">169</span>â€"<span class="lpage" tagx="lpage" title="lpage">75</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27091227">27091227</a></span></span></li> <li tag="ref"><a name="CIT0054" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jain</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tiwari</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Verma</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2018</span>). <span class="mixed-article-title" title="mixed-article-title">Ultrasound-based triggered drug delivery to tumors</span>. <span class="source" tagx="source" title="source">Drug Deliv Transl Res</span><span class="volume" tagx="volume" title="volume">8</span>:<span class="fpage" tagx="fpage" title="fpage">150</span>â€"<span class="lpage" tagx="lpage" title="lpage">64</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29204925">29204925</a></span></span></li> <li tag="ref"><a name="CIT0055" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jie</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guo</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ouyang</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title">Tumor ablation using novel photothermal NaxWO3 nanoparticles against breast cancer osteolytic bone metastasis</span>. <span class="source" tagx="source" title="source">Int J Nanomedicine</span><span class="volume" tagx="volume" title="volume">14</span>:<span class="fpage" tagx="fpage" title="fpage">7353</span>â€"<span class="lpage" tagx="lpage" title="lpage">62</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31571856">31571856</a></span></span></li> <li tag="ref"><a name="CIT0056" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kagiya</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span></span> (<span class="year" tagx="year" title="year">2015</span>). <span class="mixed-article-title" title="mixed-article-title">MicroRNAs and osteolytic bone metastasis: the roles of MicroRNAs in tumor-induced osteoclast differentiation</span>. <span class="source" tagx="source" title="source">J Clin Med</span><span class="volume" tagx="volume" title="volume">4</span>:<span class="fpage" tagx="fpage" title="fpage">1741</span>â€"<span class="lpage" tagx="lpage" title="lpage">52</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26343739">26343739</a></span></span></li> <li tag="ref"><a name="CIT0057" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Karimi</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ghasemi</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zangabad</span><span class="given-names" tagx="given-names" title="given-names">PS</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems</span>. <span class="source" tagx="source" title="source">Chem Soc Rev</span><span class="volume" tagx="volume" title="volume">45</span>:<span class="fpage" tagx="fpage" title="fpage">1457</span>â€"<span class="lpage" tagx="lpage" title="lpage">501</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26776487">26776487</a></span></span></li> <li tag="ref"><a name="CIT0058" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kaur</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Willsmore</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gulati</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Titanium wire implants with nanotube arrays: a study model for localized cancer treatment</span>. <span class="source" tagx="source" title="source">Biomaterials</span><span class="volume" tagx="volume" title="volume">101</span>:<span class="fpage" tagx="fpage" title="fpage">176</span>â€"<span class="lpage" tagx="lpage" title="lpage">88</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27289379">27289379</a></span></span></li> <li tag="ref"><a name="CIT0059" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ke</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lin</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">Synergistic dual-modified liposome improves targeting and therapeutic efficacy of bone metastasis from breast cancer</span>. <span class="source" tagx="source" title="source">Drug Deliv</span><span class="volume" tagx="volume" title="volume">24</span>:<span class="fpage" tagx="fpage" title="fpage">1680</span>â€"<span class="lpage" tagx="lpage" title="lpage">89</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29092646">29092646</a></span></span></li> <li tag="ref"><a name="CIT0060" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jeong</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Synergistic nanomedicine by combined gene and photothermal therapy</span>. <span class="source" tagx="source" title="source">Adv Drug Deliv Rev</span><span class="volume" tagx="volume" title="volume">98</span>:<span class="fpage" tagx="fpage" title="fpage">99</span>â€"<span class="lpage" tagx="lpage" title="lpage">112</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26748259">26748259</a></span></span></li> <li tag="ref"><a name="CIT0061" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Koto</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Murata</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sawai</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">Cytotoxic effects of zoledronic acid-loaded hydroxyapatite and bone cement in malignant tumors</span>. <span class="source" tagx="source" title="source">Oncol Lett</span><span class="volume" tagx="volume" title="volume">14</span>:<span class="fpage" tagx="fpage" title="fpage">1648</span>â€"<span class="lpage" tagx="lpage" title="lpage">56</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28789391">28789391</a></span></span></li> <li tag="ref"><a name="CIT0062" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kozusko</span><span class="given-names" tagx="given-names" title="given-names">SD</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Riccio</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Goulart</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2018</span>). <span class="mixed-article-title" title="mixed-article-title">Chitosan as a bone scaffold biomaterial</span>. <span class="source" tagx="source" title="source">J Craniofac Surg</span><span class="volume" tagx="volume" title="volume">29</span>:<span class="fpage" tagx="fpage" title="fpage">1788</span>â€"<span class="lpage" tagx="lpage" title="lpage">93</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30157141">30157141</a></span></span></li> <li tag="ref"><a name="CIT0063" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kwakwa</span><span class="given-names" tagx="given-names" title="given-names">KA</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sterling</span><span class="given-names" tagx="given-names" title="given-names">JA.</span></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">Integrin alpha v beta 3 signaling in tumor-induced bone disease</span>. <span class="source" tagx="source" title="source">Cancers</span><span class="volume" tagx="volume" title="volume">9</span>:<span class="fpage" tagx="fpage" title="fpage">84</span>.</span></li> <li tag="ref"><a name="CIT0064" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">E-U</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lim</span><span class="given-names" tagx="given-names" title="given-names">H-C</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hong</span><span class="given-names" tagx="given-names" title="given-names">J-Y</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Bone regenerative efficacy of biphasic calcium phosphate collagen composite as a carrier of rhBMP-2</span>. <span class="source" tagx="source" title="source">Clin Oral Implants Res</span><span class="volume" tagx="volume" title="volume">27</span>:<span class="fpage" tagx="fpage" title="fpage">e91</span>â€"<span class="lpage" tagx="lpage" title="lpage">9</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25675839">25675839</a></span></span></li> <li tag="ref"><a name="CIT0065" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">SK</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Park</span><span class="given-names" tagx="given-names" title="given-names">K-K</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">H-J</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2015</span>). <span class="mixed-article-title" title="mixed-article-title">Platycodin D blocks breast cancer-induced bone destruction by inhibiting osteoclastogenesis and the growth of breast cancer cells</span>. <span class="source" tagx="source" title="source">Cell Physiol Biochem</span><span class="volume" tagx="volume" title="volume">36</span>:<span class="fpage" tagx="fpage" title="fpage">1809</span>â€"<span class="lpage" tagx="lpage" title="lpage">20</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26184636">26184636</a></span></span></li> <li tag="ref"><a name="CIT0066" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Feng</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lu</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title">Artemisinin inhibits breast cancer-induced osteolysis by inhibiting osteoclast formation and breast cancer cell proliferation</span>. <span class="source" tagx="source" title="source">J Cell Physiol</span><span class="volume" tagx="volume" title="volume">234</span>:<span class="fpage" tagx="fpage" title="fpage">12663</span>â€"<span class="lpage" tagx="lpage" title="lpage">75</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30536376">30536376</a></span></span></li> <li tag="ref"><a name="CIT0067" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xiao</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2012</span>). <span class="mixed-article-title" title="mixed-article-title">Plumbagin inhibits breast tumor bone metastasis and osteolysis by modulating the tumor-bone microenvironment</span>. <span class="source" tagx="source" title="source">Curr Mol Med</span><span class="volume" tagx="volume" title="volume">12</span>:<span class="fpage" tagx="fpage" title="fpage">967</span>â€"<span class="lpage" tagx="lpage" title="lpage">81</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22574935">22574935</a></span></span></li> <li tag="ref"><a name="CIT0068" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">Engineered multifunctional nanomedicine for simultaneous stereotactic chemotherapy and inhibited osteolysis in an orthotopic model of bone metastasis</span>. <span class="source" tagx="source" title="source">Adv Mater</span><span class="volume" tagx="volume" title="volume">29</span>:<span class="fpage" tagx="fpage" title="fpage">1605754</span>.</span></li> <li tag="ref"><a name="CIT0069" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lima</span><span class="given-names" tagx="given-names" title="given-names">AC</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ferreira</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Reis</span><span class="given-names" tagx="given-names" title="given-names">RL</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title">Biodegradable polymers: an update on drug delivery in bone and cartilage diseases</span>. <span class="source" tagx="source" title="source">Expert Opin Drug Deliv</span><span class="volume" tagx="volume" title="volume">16</span>:<span class="fpage" tagx="fpage" title="fpage">795</span>â€"<span class="lpage" tagx="lpage" title="lpage">813</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31220958">31220958</a></span></span></li> <li tag="ref"><a name="CIT0070" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lipton</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fizazi</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Stopeck</span><span class="given-names" tagx="given-names" title="given-names">AT</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics</span>. <span class="source" tagx="source" title="source">Eur J Cancer</span><span class="volume" tagx="volume" title="volume">53</span>:<span class="fpage" tagx="fpage" title="fpage">75</span>â€"<span class="lpage" tagx="lpage" title="lpage">83</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26693901">26693901</a></span></span></li> <li tag="ref"><a name="CIT0071" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">YJ</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bhattarai</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dai</span><span class="given-names" tagx="given-names" title="given-names">ZF</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title">Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer</span>. <span class="source" tagx="source" title="source">Chem Soc Rev</span><span class="volume" tagx="volume" title="volume">48</span>:<span class="fpage" tagx="fpage" title="fpage">2053</span>â€"<span class="lpage" tagx="lpage" title="lpage">108</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30259015">30259015</a></span></span></li> <li tag="ref"><a name="CIT0072" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">Y-Q</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hong</span><span class="given-names" tagx="given-names" title="given-names">Z-L</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhan</span><span class="given-names" tagx="given-names" title="given-names">L-B</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Wedelolactone enhances osteoblastogenesis by regulating Wnt/beta-catenin signaling pathway but suppresses osteoclastogenesis by NF-kappa B/c-fos/NFATc1 pathway</span>. <span class="source" tagx="source" title="source">Sci Rep</span><span class="volume" tagx="volume" title="volume">6</span>:<span class="fpage" tagx="fpage" title="fpage">32260</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27558652">27558652</a></span></span></li> <li tag="ref"><a name="CIT0073" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Romanova</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title">Alendronate-modified polymeric micelles for the treatment of breast cancer bone metastasis</span>. <span class="source" tagx="source" title="source">Mol Pharm</span><span class="volume" tagx="volume" title="volume">16</span>:<span class="fpage" tagx="fpage" title="fpage">2872</span>â€"<span class="lpage" tagx="lpage" title="lpage">83</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31150251">31150251</a></span></span></li> <li tag="ref"><a name="CIT0074" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xiong</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">The smart drug delivery system and its clinical potential</span>. <span class="source" tagx="source" title="source">Theranostics</span><span class="volume" tagx="volume" title="volume">6</span>:<span class="fpage" tagx="fpage" title="fpage">1306</span>â€"<span class="lpage" tagx="lpage" title="lpage">23</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27375781">27375781</a></span></span></li> <li tag="ref"><a name="CIT0075" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">R-X</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yuan</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2018</span>). <span class="mixed-article-title" title="mixed-article-title">Knockdown of bone morphogenetic proteins type 1a receptor (BMPR1a) in breast cancer cells protects bone from breast cancer-induced osteolysis by suppressing RANKL expression</span>. <span class="source" tagx="source" title="source">Cell Physiol Biochem</span><span class="volume" tagx="volume" title="volume">45</span>:<span class="fpage" tagx="fpage" title="fpage">1759</span>â€"<span class="lpage" tagx="lpage" title="lpage">71</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29495003">29495003</a></span></span></li> <li tag="ref"><a name="CIT0076" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lu</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mu</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wei</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2011</span>). <span class="mixed-article-title" title="mixed-article-title">VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging Î±4Î²1-positive osteoclast progenitors</span> . <span class="source" tagx="source" title="source">Cancer Cell</span><span class="volume" tagx="volume" title="volume">20</span>:<span class="fpage" tagx="fpage" title="fpage">701</span>â€"<span class="lpage" tagx="lpage" title="lpage">14</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22137794">22137794</a></span></span></li> <li tag="ref"><a name="CIT0077" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lu</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">QQ</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">GH</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2009</span>). <span class="mixed-article-title" title="mixed-article-title">ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis</span>. <span class="source" tagx="source" title="source">Genes &amp;amp; Development</span><span class="volume" tagx="volume" title="volume">23</span>:<span class="fpage" tagx="fpage" title="fpage">1882</span>â€"<span class="lpage" tagx="lpage" title="lpage">94</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19608765">19608765</a></span></span></li> <li tag="ref"><a name="CIT0078" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Luo</span><span class="given-names" tagx="given-names" title="given-names">KW</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ko</span><span class="given-names" tagx="given-names" title="given-names">CH</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yue</span><span class="given-names" tagx="given-names" title="given-names">GGL</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2015</span>). <span class="mixed-article-title" title="mixed-article-title">The combined use of <i>Camellia sinensis</i> and metronomic zoledronic acid in a breast cancer-induced osteolysis mouse model</span>. <span class="source" tagx="source" title="source">J Cancer Res Clin Oncol</span><span class="volume" tagx="volume" title="volume">141</span>:<span class="fpage" tagx="fpage" title="fpage">1025</span>â€"<span class="lpage" tagx="lpage" title="lpage">36</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25431338">25431338</a></span></span></li> <li tag="ref"><a name="CIT0079" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ma</span><span class="given-names" tagx="given-names" title="given-names">GT</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">SK</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Park</span><span class="given-names" tagx="given-names" title="given-names">K-K</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2018</span>). <span class="mixed-article-title" title="mixed-article-title">Artemisinin-daumone hybrid inhibits cancer cell-mediated osteolysis by targeting cancer cells and osteoclasts</span>. <span class="source" tagx="source" title="source">Cell Physiol Biochem</span><span class="volume" tagx="volume" title="volume">49</span>:<span class="fpage" tagx="fpage" title="fpage">1460</span>â€"<span class="lpage" tagx="lpage" title="lpage">75</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30205376">30205376</a></span></span></li> <li tag="ref"><a name="CIT0080" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Macedo</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ladeira</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pinho</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">Bone metastases: an overview</span>. <span class="source" tagx="source" title="source">Oncol Rev</span><span class="volume" tagx="volume" title="volume">11</span>:<span class="fpage" tagx="fpage" title="fpage">321</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28584570">28584570</a></span></span></li> <li tag="ref"><a name="CIT0081" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Martin</span><span class="given-names" tagx="given-names" title="given-names">V</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bettencourt</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span> (<span class="year" tagx="year" title="year">2018</span>). <span class="mixed-article-title" title="mixed-article-title">Bone regeneration: biomaterials as local delivery systems with improved osteoinductive properties</span>. <span class="source" tagx="source" title="source">Mater Sci Eng C Mater Biol Appl</span><span class="volume" tagx="volume" title="volume">82</span>:<span class="fpage" tagx="fpage" title="fpage">363</span>â€"<span class="lpage" tagx="lpage" title="lpage">71</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29025670">29025670</a></span></span></li> <li tag="ref"><a name="CIT0082" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">MÃ¼ller</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Neufurth</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2018</span>). <span class="mixed-article-title" title="mixed-article-title">Amorphous, smart, and bioinspired polyphosphate nano/microparticles: a biomaterial for regeneration and repair of osteo-articular impairments in-situ</span>. <span class="source" tagx="source" title="source">IJMS</span><span class="volume" tagx="volume" title="volume">19</span>:<span class="fpage" tagx="fpage" title="fpage">427</span>.</span></li> <li tag="ref"><a name="CIT0083" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Newman</span><span class="given-names" tagx="given-names" title="given-names">MR</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Benoit</span><span class="given-names" tagx="given-names" title="given-names">DSW.</span></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Local and targeted drug delivery for bone regeneration</span>. <span class="source" tagx="source" title="source">Curr Opin Biotechnol</span><span class="volume" tagx="volume" title="volume">40</span>:<span class="fpage" tagx="fpage" title="fpage">125</span>â€"<span class="lpage" tagx="lpage" title="lpage">32</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27064433">27064433</a></span></span></li> <li tag="ref"><a name="CIT0084" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nooh</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">YL</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sato</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">Intra-tumor delivery of zoledronate mitigates metastasis-induced osteolysis superior to systemic administration</span>. <span class="source" tagx="source" title="source">J Bone Oncol</span><span class="volume" tagx="volume" title="volume">6</span>:<span class="fpage" tagx="fpage" title="fpage">8</span>â€"<span class="lpage" tagx="lpage" title="lpage">15</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28138422">28138422</a></span></span></li> <li tag="ref"><a name="CIT0085" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Norouzi</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nazari</span><span class="given-names" tagx="given-names" title="given-names">B</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Miller</span><span class="given-names" tagx="given-names" title="given-names">DW.</span></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Injectable hydrogel-based drug delivery systems for local cancer therapy</span>. <span class="source" tagx="source" title="source">Drug Discov Today</span><span class="volume" tagx="volume" title="volume">21</span>:<span class="fpage" tagx="fpage" title="fpage">1835</span>â€"<span class="lpage" tagx="lpage" title="lpage">49</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27423369">27423369</a></span></span></li> <li tag="ref"><a name="CIT0086" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Oâ€™Carrigan</span><span class="given-names" tagx="given-names" title="given-names">B</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wong</span><span class="given-names" tagx="given-names" title="given-names">MHF</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Willson</span><span class="given-names" tagx="given-names" title="given-names">ML</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">Bisphosphonates and other bone agents for breast cancer</span>. <span class="source" tagx="source" title="source">Coch Datab System Rev</span><span class="volume" tagx="volume" title="volume">2</span>:<span class="fpage" tagx="fpage" title="fpage">CD003474</span>.</span></li> <li tag="ref"><a name="CIT0087" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Oledzka</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pachowska</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">OrÅ‚owska</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">Pamidronate-conjugated biodegradable branched copolyester carriers: synthesis and characterization</span>. <span class="source" tagx="source" title="source">Molecules</span><span class="volume" tagx="volume" title="volume">22</span>:<span class="fpage" tagx="fpage" title="fpage">1063</span>.</span></li> <li tag="ref"><a name="CIT0088" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Olthof</span><span class="given-names" tagx="given-names" title="given-names">MGL</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kempen</span><span class="given-names" tagx="given-names" title="given-names">DHR</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Herrick</span><span class="given-names" tagx="given-names" title="given-names">JL</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2018</span>). <span class="mixed-article-title" title="mixed-article-title">Effect of different sustained bone morphogenetic protein-2 release kinetics on bone formation in poly(propylene fumarate) scaffolds</span>. <span class="source" tagx="source" title="source">J Biomed Mater Res B Appl Biomater</span><span class="volume" tagx="volume" title="volume">106</span>:<span class="fpage" tagx="fpage" title="fpage">477</span>â€"<span class="lpage" tagx="lpage" title="lpage">87</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28186684">28186684</a></span></span></li> <li tag="ref"><a name="CIT0089" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">PalamÃ </span><span class="given-names" tagx="given-names" title="given-names">IE</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Arcadio</span><span class="given-names" tagx="given-names" title="given-names">V</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dâ€™Amone</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">Therapeutic PCL scaffold for reparation of resected osteosarcoma defect</span>. <span class="source" tagx="source" title="source">Sci Rep</span><span class="volume" tagx="volume" title="volume">7</span>:<span class="fpage" tagx="fpage" title="fpage">12672</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28978922">28978922</a></span></span></li> <li tag="ref"><a name="CIT0090" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Perez-Herrero</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fernandez-Medarde</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span> (<span class="year" tagx="year" title="year">2015</span>). <span class="mixed-article-title" title="mixed-article-title">Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy</span>. <span class="source" tagx="source" title="source">Eur J Pharm Biopharm</span><span class="volume" tagx="volume" title="volume">93</span>:<span class="fpage" tagx="fpage" title="fpage">52</span>â€"<span class="lpage" tagx="lpage" title="lpage">79</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25813885">25813885</a></span></span></li> <li tag="ref"><a name="CIT0091" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pore</span><span class="given-names" tagx="given-names" title="given-names">SK</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hahm</span><span class="given-names" tagx="given-names" title="given-names">E-R</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Latoche</span><span class="given-names" tagx="given-names" title="given-names">JD</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2018</span>). <span class="mixed-article-title" title="mixed-article-title">Prevention of breast cancer-induced osteolytic bone resorption by benzyl isothiocyanate</span>. <span class="source" tagx="source" title="source">Carcinogenesis</span><span class="volume" tagx="volume" title="volume">39</span>:<span class="fpage" tagx="fpage" title="fpage">134</span>â€"<span class="lpage" tagx="lpage" title="lpage">45</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29040431">29040431</a></span></span></li> <li tag="ref"><a name="CIT0092" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Posadowska</span><span class="given-names" tagx="given-names" title="given-names">U</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Parizek</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Filova</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2015</span>). <span class="mixed-article-title" title="mixed-article-title">Injectable nanoparticle-loaded hydrogel system for local delivery of sodium alendronate</span>. <span class="source" tagx="source" title="source">Int J Pharm</span><span class="volume" tagx="volume" title="volume">485</span>:<span class="fpage" tagx="fpage" title="fpage">31</span>â€"<span class="lpage" tagx="lpage" title="lpage">40</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25747455">25747455</a></span></span></li> <li tag="ref"><a name="CIT0093" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Probert</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dottorini</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Speakman</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title">Communication of prostate cancer cells with bone cells via extracellular vesicle RNA; a potential mechanism of metastasis</span>. <span class="source" tagx="source" title="source">Oncogene</span><span class="volume" tagx="volume" title="volume">38</span>:<span class="fpage" tagx="fpage" title="fpage">1751</span>â€"<span class="lpage" tagx="lpage" title="lpage">63</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30353168">30353168</a></span></span></li> <li tag="ref"><a name="CIT0094" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Qiao</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cui</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">Targeting osteocytes to attenuate early breast cancer bone metastasis by theranostic upconversion nanoparticles with responsive plumbagin release</span>. <span class="source" tagx="source" title="source">ACS Nano</span><span class="volume" tagx="volume" title="volume">11</span>:<span class="fpage" tagx="fpage" title="fpage">7259</span>â€"<span class="lpage" tagx="lpage" title="lpage">73</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28692257">28692257</a></span></span></li> <li tag="ref"><a name="CIT0095" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rahmanian</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Naghib</span><span class="given-names" tagx="given-names" title="given-names">SM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Seyfoori</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">Tricalcium phosphate nanostructures loaded with bisphosphonate as potential anticancer agents</span>. <span class="source" tagx="source" title="source">J Ceramic Sci Technol</span><span class="volume" tagx="volume" title="volume">8</span>:<span class="fpage" tagx="fpage" title="fpage">505</span>â€"<span class="lpage" tagx="lpage" title="lpage">12</span>.</span></li> <li tag="ref"><a name="CIT0096" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rahmanian</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Seyfoori</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dehghan</span><span class="given-names" tagx="given-names" title="given-names">MM</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title">Multifunctional gelatin-tricalcium phosphate porous nanocomposite scaffolds for tissue engineering and local drug delivery: inÂ vitro and inÂ vivo studies</span>. <span class="source" tagx="source" title="source">J Taiwan Inst Chem Eng</span><span class="volume" tagx="volume" title="volume">101</span>:<span class="fpage" tagx="fpage" title="fpage">214</span>â€"<span class="lpage" tagx="lpage" title="lpage">20</span>.</span></li> <li tag="ref"><a name="CIT0097" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Robert</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Reinhold</span><span class="given-names" tagx="given-names" title="given-names">WC.</span></span></span> (<span class="year" tagx="year" title="year">2015</span>). <span class="mixed-article-title" title="mixed-article-title">Bisphosphonates as new anticancer agents?</span><span class="source" tagx="source" title="source">Bull Cancer</span><span class="volume" tagx="volume" title="volume">102</span>:<span class="fpage" tagx="fpage" title="fpage">297</span>â€"<span class="lpage" tagx="lpage" title="lpage">99</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26042254">26042254</a></span></span></li> <li tag="ref"><a name="CIT0098" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ross</span><span class="given-names" tagx="given-names" title="given-names">MH</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Esser</span><span class="given-names" tagx="given-names" title="given-names">AK</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fox</span><span class="given-names" tagx="given-names" title="given-names">GC</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">Bone-induced expression of integrin Î²3 enables targeted nanotherapy of breast cancer metastases</span>. <span class="source" tagx="source" title="source">Cancer Res</span><span class="volume" tagx="volume" title="volume">77</span>:<span class="fpage" tagx="fpage" title="fpage">6299</span>â€"<span class="lpage" tagx="lpage" title="lpage">312</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28855208">28855208</a></span></span></li> <li tag="ref"><a name="CIT0099" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rudnick-Glick</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Corem-Salkmon</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Grinberg</span><span class="given-names" tagx="given-names" title="given-names">I</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Targeted drug delivery of near IR fluorescent doxorubicin-conjugated poly(ethylene glycol) bisphosphonate nanoparticles for diagnosis and therapy of primary and metastatic bone cancer in a mouse model</span>. <span class="source" tagx="source" title="source">J Nanobiotechnol</span><span class="volume" tagx="volume" title="volume">14</span>:<span class="fpage" tagx="fpage" title="fpage">80</span>.</span></li> <li tag="ref"><a name="CIT0100" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ryu</span><span class="given-names" tagx="given-names" title="given-names">T-K</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kang</span><span class="given-names" tagx="given-names" title="given-names">R-H</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jeong</span><span class="given-names" tagx="given-names" title="given-names">K-Y</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Bone-targeted delivery of nanodiamond-based drug carriers conjugated with alendronate for potential osteoporosis treatment</span>. <span class="source" tagx="source" title="source">J Control Release</span><span class="volume" tagx="volume" title="volume">232</span>:<span class="fpage" tagx="fpage" title="fpage">152</span>â€"<span class="lpage" tagx="lpage" title="lpage">60</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27094604">27094604</a></span></span></li> <li tag="ref"><a name="CIT0101" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Santini</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Galluzzo</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zoccoli</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2010</span>). <span class="mixed-article-title" title="mixed-article-title">New molecular targets in bone metastases</span>. <span class="source" tagx="source" title="source">Cancer Treat Rev</span><span class="volume" tagx="volume" title="volume">36</span>:<span class="fpage" tagx="fpage" title="fpage">S6</span>â€"<span class="lpage" tagx="lpage" title="lpage">S10</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21129612">21129612</a></span></span></li> <li tag="ref"><a name="CIT0102" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Santini</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Stumbo</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Spoto</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2015</span>). <span class="mixed-article-title" title="mixed-article-title">Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence</span>. <span class="source" tagx="source" title="source">Breast Cancer Res</span><span class="volume" tagx="volume" title="volume">17</span>:<span class="fpage" tagx="fpage" title="fpage">121</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26328589">26328589</a></span></span></li> <li tag="ref"><a name="CIT0103" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Saracino</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Luciano</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Battafarano</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Nanoparticles-based treatment for bone metastasis</span>. <span class="source" tagx="source" title="source">Curr Drug Targets</span><span class="volume" tagx="volume" title="volume">17</span>:<span class="fpage" tagx="fpage" title="fpage">303</span>â€"<span class="lpage" tagx="lpage" title="lpage">10</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25915486">25915486</a></span></span></li> <li tag="ref"><a name="CIT0104" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Saravanakumar</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">WJ.</span></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">Reactive-oxygen-species-responsive drug delivery systems: promises and challenges</span>. <span class="source" tagx="source" title="source">Adv Sci</span><span class="volume" tagx="volume" title="volume">4</span>:<span class="fpage" tagx="fpage" title="fpage">1600124</span>.</span></li> <li tag="ref"><a name="CIT0105" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sarigol-Calamak</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hascicek</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span></span> (<span class="year" tagx="year" title="year">2018</span>). <span class="chapter-title" tagx="chapter-title" title="chapter-title">Tissue scaffolds as a local drug delivery system for bone regeneration</span> In: <span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chun</span><span class="given-names" tagx="given-names" title="given-names">HJ</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Park</span><span class="given-names" tagx="given-names" title="given-names">CH</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kwon</span><span class="given-names" tagx="given-names" title="given-names">IK</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Khang</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, eds.</span><span class="source" tagx="source" title="source">Cutting-edge enabling technologies for regenerative medicine</span>. <span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">Singapore, Singapore</span>: <span class="publisher-name" tagx="publisher-name" title="publisher-name">Springer</span>, <span class="fpage" tagx="fpage" title="fpage">475</span>â€"<span class="lpage" tagx="lpage" title="lpage">93</span>.</span></li> <li tag="ref"><a name="CIT0106" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sethi</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dai</span><span class="given-names" tagx="given-names" title="given-names">XD</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Winter</span><span class="given-names" tagx="given-names" title="given-names">CG</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2011</span>). <span class="mixed-article-title" title="mixed-article-title">Tumor-derived jagged1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells</span>. <span class="source" tagx="source" title="source">Cancer Cell</span><span class="volume" tagx="volume" title="volume">19</span>:<span class="fpage" tagx="fpage" title="fpage">192</span>â€"<span class="lpage" tagx="lpage" title="lpage">205</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21295524">21295524</a></span></span></li> <li tag="ref"><a name="CIT0107" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shupp</span><span class="given-names" tagx="given-names" title="given-names">AB</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kolb</span><span class="given-names" tagx="given-names" title="given-names">AD</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mukhopadhyay</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2018</span>). <span class="mixed-article-title" title="mixed-article-title">Cancer metastases to bone: concepts, mechanisms, and interactions with bone osteoblasts</span>. <span class="source" tagx="source" title="source">Cancers</span><span class="volume" tagx="volume" title="volume">10</span>:<span class="fpage" tagx="fpage" title="fpage">182</span>.</span></li> <li tag="ref"><a name="CIT0108" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Song</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Murphy</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">CS</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2018</span>). <span class="mixed-article-title" title="mixed-article-title">Current development of biodegradable polymeric materials for biomedical applications</span>. <span class="source" tagx="source" title="source">Drug Des Devel Ther</span><span class="volume" tagx="volume" title="volume">12</span>:<span class="fpage" tagx="fpage" title="fpage">3117</span>â€"<span class="lpage" tagx="lpage" title="lpage">45</span>.</span></li> <li tag="ref"><a name="CIT0109" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Stapleton</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sawamoto</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Almeciga-Diaz</span><span class="given-names" tagx="given-names" title="given-names">CJ</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">Development of bone targeting drugs</span>. <span class="source" tagx="source" title="source">IJMS</span><span class="volume" tagx="volume" title="volume">18</span>:<span class="fpage" tagx="fpage" title="fpage">1345</span>.</span></li> <li tag="ref"><a name="CIT0110" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Stopeck</span><span class="given-names" tagx="given-names" title="given-names">AT</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fizazi</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Body</span><span class="given-names" tagx="given-names" title="given-names">JJ</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer</span>. <span class="source" tagx="source" title="source">Support Care Cancer</span><span class="volume" tagx="volume" title="volume">24</span>:<span class="fpage" tagx="fpage" title="fpage">447</span>â€"<span class="lpage" tagx="lpage" title="lpage">55</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26335402">26335402</a></span></span></li> <li tag="ref"><a name="CIT0111" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Stopeck</span><span class="given-names" tagx="given-names" title="given-names">AT</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lipton</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Body</span><span class="given-names" tagx="given-names" title="given-names">J-J</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2010</span>). <span class="mixed-article-title" title="mixed-article-title">Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study</span>. <span class="source" tagx="source" title="source">J Clin Oncol</span><span class="volume" tagx="volume" title="volume">28</span>:<span class="fpage" tagx="fpage" title="fpage">5132</span>â€"<span class="lpage" tagx="lpage" title="lpage">39</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21060033">21060033</a></span></span></li> <li tag="ref"><a name="CIT0112" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Strazic-Geljic</span><span class="given-names" tagx="given-names" title="given-names">I</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guberovic</span><span class="given-names" tagx="given-names" title="given-names">I</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Didak</span><span class="given-names" tagx="given-names" title="given-names">B</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Gallium, a promising candidate to disrupt the vicious cycle driving osteolytic metastases</span>. <span class="source" tagx="source" title="source">Biochem Pharmacol</span><span class="volume" tagx="volume" title="volume">116</span>:<span class="fpage" tagx="fpage" title="fpage">11</span>â€"<span class="lpage" tagx="lpage" title="lpage">21</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27378505">27378505</a></span></span></li> <li tag="ref"><a name="CIT0113" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Suk</span><span class="given-names" tagx="given-names" title="given-names">JS</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xu</span><span class="given-names" tagx="given-names" title="given-names">QG</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">PEGylation as a strategy for improving nanoparticle-based drug and gene delivery</span>. <span class="source" tagx="source" title="source">Adv Drug Deliv Rev</span><span class="volume" tagx="volume" title="volume">99</span>:<span class="fpage" tagx="fpage" title="fpage">28</span>â€"<span class="lpage" tagx="lpage" title="lpage">51</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26456916">26456916</a></span></span></li> <li tag="ref"><a name="CIT0114" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sun</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">YY</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ma</span><span class="given-names" tagx="given-names" title="given-names">XY</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Mitochondria-targeted hydroxyapatite nanoparticles for selective growth inhibition of lung cancer inÂ vitro and inÂ vivo</span>. <span class="source" tagx="source" title="source">ACS Appl Mater Interfaces</span><span class="volume" tagx="volume" title="volume">8</span>:<span class="fpage" tagx="fpage" title="fpage">25680</span>â€"<span class="lpage" tagx="lpage" title="lpage">90</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27602785">27602785</a></span></span></li> <li tag="ref"><a name="CIT0115" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sun</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ge</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jin</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title">Bone-targeted nanoplatform combining zoledronate and photothermal therapy to treat breast cancer bone metastasis</span>. <span class="source" tagx="source" title="source">ACS Nano</span><span class="volume" tagx="volume" title="volume">13</span>:<span class="fpage" tagx="fpage" title="fpage">7556</span>â€"<span class="lpage" tagx="lpage" title="lpage">67</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31259530">31259530</a></span></span></li> <li tag="ref"><a name="CIT0116" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sun</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Han</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Bone-targeted mesoporous silica nanocarrier anchored by zoledronate for cancer bone metastasis</span>. <span class="source" tagx="source" title="source">Langmuir</span><span class="volume" tagx="volume" title="volume">32</span>:<span class="fpage" tagx="fpage" title="fpage">9237</span>â€"<span class="lpage" tagx="lpage" title="lpage">44</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27531422">27531422</a></span></span></li> <li tag="ref"><a name="CIT0117" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sun</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title">Licorice isoliquiritigenin-encapsulated mesoporous silica nanoparticles for osteoclast inhibition and bone loss prevention</span>. <span class="source" tagx="source" title="source">Theranostics</span><span class="volume" tagx="volume" title="volume">9</span>:<span class="fpage" tagx="fpage" title="fpage">5183</span>â€"<span class="lpage" tagx="lpage" title="lpage">99</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31410209">31410209</a></span></span></li> <li tag="ref"><a name="CIT0118" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tan</span><span class="given-names" tagx="given-names" title="given-names">L-L</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Song</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">SX-A</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Ca<sup>2+</sup>, pH and thermo triple-responsive mechanized Zr-based MOFs for on-command drug release in bone diseases</span>. <span class="source" tagx="source" title="source">J Mater Chem B</span><span class="volume" tagx="volume" title="volume">4</span>:<span class="fpage" tagx="fpage" title="fpage">135</span>â€"<span class="lpage" tagx="lpage" title="lpage">40</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32262817">32262817</a></span></span></li> <li tag="ref"><a name="CIT0119" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tang</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Qian</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Self-assembling bisphosphonates into nanofibers to enhance their inhibitory capacity on bone resorption</span>. <span class="source" tagx="source" title="source">Nanoscale</span><span class="volume" tagx="volume" title="volume">8</span>:<span class="fpage" tagx="fpage" title="fpage">10570</span>â€"<span class="lpage" tagx="lpage" title="lpage">75</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27153349">27153349</a></span></span></li> <li tag="ref"><a name="CIT0120" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Thummuri</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jeengar</span><span class="given-names" tagx="given-names" title="given-names">MK</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shrivastava</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2015</span>). <span class="mixed-article-title" title="mixed-article-title">Thymoquinone prevents RANKL-induced osteoclastogenesis activation and osteolysis in an inÂ vivo model of inflammation by suppressing NF-KB and MAPK Signalling</span>. <span class="source" tagx="source" title="source">Pharmacol Res</span><span class="volume" tagx="volume" title="volume">99</span>:<span class="fpage" tagx="fpage" title="fpage">63</span>â€"<span class="lpage" tagx="lpage" title="lpage">73</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26022736">26022736</a></span></span></li> <li tag="ref"><a name="CIT0121" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Turpin</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Duterque-Coquillaud</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Vieillard</span><span class="given-names" tagx="given-names" title="given-names">M-H.</span></span></span> (<span class="year" tagx="year" title="year">2020</span>). <span class="mixed-article-title" title="mixed-article-title">Bone metastasis: current state of play</span>. <span class="source" tagx="source" title="source">Transl Oncol</span><span class="volume" tagx="volume" title="volume">13</span>:<span class="fpage" tagx="fpage" title="fpage">308</span>â€"<span class="lpage" tagx="lpage" title="lpage">20</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31877463">31877463</a></span></span></li> <li tag="ref"><a name="CIT0122" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ulbrich</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hola</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Subr</span><span class="given-names" tagx="given-names" title="given-names">V</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Targeted drug delivery with polymers and magnetic nanoparticles: covalent and noncovalent approaches, release control, and clinical studies</span>. <span class="source" tagx="source" title="source">Chem Rev</span><span class="volume" tagx="volume" title="volume">116</span>:<span class="fpage" tagx="fpage" title="fpage">5338</span>â€"<span class="lpage" tagx="lpage" title="lpage">431</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27109701">27109701</a></span></span></li> <li tag="ref"><a name="CIT0123" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Vanderburgh</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hill</span><span class="given-names" tagx="given-names" title="given-names">JL</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gupta</span><span class="given-names" tagx="given-names" title="given-names">MK</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2020</span>). <span class="mixed-article-title" title="mixed-article-title">Tuning ligand density to optimize pharmacokinetics of targeted nanoparticles for dual protection against tumor-induced bone destruction</span>. <span class="source" tagx="source" title="source">Acs Nano</span><span class="volume" tagx="volume" title="volume">14</span>:<span class="fpage" tagx="fpage" title="fpage">311</span>â€"<span class="lpage" tagx="lpage" title="lpage">27</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31894963">31894963</a></span></span></li> <li tag="ref"><a name="CIT0124" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Vanderburgh</span><span class="given-names" tagx="given-names" title="given-names">JP</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kwakwa</span><span class="given-names" tagx="given-names" title="given-names">KA</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Werfel</span><span class="given-names" tagx="given-names" title="given-names">TA</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title">Systemic delivery of a Gli inhibitor via polymeric nanocarriers inhibits tumor-induced bone disease</span>. <span class="source" tagx="source" title="source">J Controlled Release</span><span class="volume" tagx="volume" title="volume">311-312</span>:<span class="fpage" tagx="fpage" title="fpage">257</span>â€"<span class="lpage" tagx="lpage" title="lpage">72</span>.</span></li> <li tag="ref"><a name="CIT0125" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Vinay</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">KusumDevi</span><span class="given-names" tagx="given-names" title="given-names">V.</span></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Potential of targeted drug delivery system for the treatment of bone metastasis</span>. <span class="source" tagx="source" title="source">Drug Deliv</span><span class="volume" tagx="volume" title="volume">23</span>:<span class="fpage" tagx="fpage" title="fpage">21</span>â€"<span class="lpage" tagx="lpage" title="lpage">9</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/24839990">24839990</a></span></span></li> <li tag="ref"><a name="CIT0126" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cai</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2018</span>). <span class="mixed-article-title" title="mixed-article-title">A targeted and pH-responsive bortezomib nanomedicine in the treatment of metastatic bone tumors</span>. <span class="source" tagx="source" title="source">ACS Appl Mater Interfaces</span><span class="volume" tagx="volume" title="volume">10</span>:<span class="fpage" tagx="fpage" title="fpage">41003</span>â€"<span class="lpage" tagx="lpage" title="lpage">11</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30403331">30403331</a></span></span></li> <li tag="ref"><a name="CIT0127" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guo</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dong</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2018</span>). <span class="mixed-article-title" title="mixed-article-title">In vivo evaluation of reduction-responsive alendronate-hyaluronan-curcumin polymer-drug conjugates for targeted therapy of bone metastatic breast cancer</span>. <span class="source" tagx="source" title="source">Mol Pharm</span><span class="volume" tagx="volume" title="volume">15</span>:<span class="fpage" tagx="fpage" title="fpage">2764</span>â€"<span class="lpage" tagx="lpage" title="lpage">69</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29792799">29792799</a></span></span></li> <li tag="ref"><a name="CIT0128" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">Q</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">He</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2018</span>). <span class="mixed-article-title" title="mixed-article-title">Multifunctional melanin-like nanoparticles for bone-targeted chemo-photothermal therapy of malignant bone tumors and osteolysis</span>. <span class="source" tagx="source" title="source">Biomaterials</span><span class="volume" tagx="volume" title="volume">183</span>:<span class="fpage" tagx="fpage" title="fpage">10</span>â€"<span class="lpage" tagx="lpage" title="lpage">9</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30144589">30144589</a></span></span></li> <li tag="ref"><a name="CIT0129" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Q</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mo</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2018</span>). <span class="mixed-article-title" title="mixed-article-title">Raddeanin A suppresses breast cancer-associated osteolysis through inhibiting osteoclasts and breast cancer cells</span>. <span class="source" tagx="source" title="source">Cell Death Dis</span><span class="volume" tagx="volume" title="volume">9</span>:<span class="fpage" tagx="fpage" title="fpage">376</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29515110">29515110</a></span></span></li> <li tag="ref"><a name="CIT0130" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shen</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2015</span>). <span class="mixed-article-title" title="mixed-article-title">Quetiapine inhibits osteoclastogenesis and prevents human breast cancer-induced bone loss through suppression of the RANKL-mediated MAPK and NF-ÎºB signaling pathways</span> . <span class="source" tagx="source" title="source">Breast Cancer Res Treat</span><span class="volume" tagx="volume" title="volume">149</span>:<span class="fpage" tagx="fpage" title="fpage">705</span>â€"<span class="lpage" tagx="lpage" title="lpage">14</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25667102">25667102</a></span></span></li> <li tag="ref"><a name="CIT0131" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">WY</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sun</span><span class="given-names" tagx="given-names" title="given-names">CX</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mao</span><span class="given-names" tagx="given-names" title="given-names">LK</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">The biological activities, chemical stability, metabolism and delivery systems of quercetin: a review</span>. <span class="source" tagx="source" title="source">Trends Food Sci Technol</span><span class="volume" tagx="volume" title="volume">56</span>:<span class="fpage" tagx="fpage" title="fpage">21</span>â€"<span class="lpage" tagx="lpage" title="lpage">38</span>.</span></li> <li tag="ref"><a name="CIT0132" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sun</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mei</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2020</span>). <span class="mixed-article-title" title="mixed-article-title">3D printed biodegradable implants as an individualized drug delivery system for local chemotherapy of osteosarcoma</span>. <span class="source" tagx="source" title="source">Mater Des</span><span class="volume" tagx="volume" title="volume">186</span>:<span class="fpage" tagx="fpage" title="fpage">108336</span>.</span></li> <li tag="ref"><a name="CIT0133" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guo</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2014</span>). <span class="mixed-article-title" title="mixed-article-title">Redox-responsive polyanhydride micelles for cancer therapy</span>. <span class="source" tagx="source" title="source">Biomaterials</span><span class="volume" tagx="volume" title="volume">35</span>:<span class="fpage" tagx="fpage" title="fpage">3080</span>â€"<span class="lpage" tagx="lpage" title="lpage">90</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/24388799">24388799</a></span></span></li> <li tag="ref"><a name="CIT0134" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">B-K</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">X-F</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">J-H</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Gold-nanorods-siRNA nanoplex for improved photothermal therapy by gene silencing</span>. <span class="source" tagx="source" title="source">Biomaterials</span><span class="volume" tagx="volume" title="volume">78</span>:<span class="fpage" tagx="fpage" title="fpage">27</span>â€"<span class="lpage" tagx="lpage" title="lpage">39</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26646625">26646625</a></span></span></li> <li tag="ref"><a name="CIT0135" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wei</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">Overexpression of suppressor of cytokine signaling 3 in dorsal root ganglion attenuates cancer-induced pain in rats</span>. <span class="source" tagx="source" title="source">Mol Pain</span><span class="volume" tagx="volume" title="volume">13</span>:<span class="fpage" tagx="fpage" title="fpage">1744806916688901</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28326931">28326931</a></span></span></li> <li tag="ref"><a name="CIT0136" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dai</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2018</span>). <span class="mixed-article-title" title="mixed-article-title">Local release of gemcitabine via in situ UV-crosslinked lipid-strengthened hydrogel for inhibiting osteosarcoma</span>. <span class="source" tagx="source" title="source">Drug Deliv</span><span class="volume" tagx="volume" title="volume">25</span>:<span class="fpage" tagx="fpage" title="fpage">1642</span>â€"<span class="lpage" tagx="lpage" title="lpage">51</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30799654">30799654</a></span></span></li> <li tag="ref"><a name="CIT0137" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">GY</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fang</span><span class="given-names" tagx="given-names" title="given-names">YZ</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2004</span>). <span class="mixed-article-title" title="mixed-article-title">Glutathione metabolism and its implications for health</span>. <span class="source" tagx="source" title="source">J Nutr</span><span class="volume" tagx="volume" title="volume">134</span>:<span class="fpage" tagx="fpage" title="fpage">489</span>â€"<span class="lpage" tagx="lpage" title="lpage">92</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14988435">14988435</a></span></span></li> <li tag="ref"><a name="CIT0138" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">XQ</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">FF</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dang</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2020</span>). <span class="mixed-article-title" title="mixed-article-title">RANKL/RANK system-based mechanism for breast cancer bone metastasis and related therapeutic strategies</span>. <span class="source" tagx="source" title="source">Front Cell Dev Biol</span><span class="volume" tagx="volume" title="volume">8</span>:<span class="fpage" tagx="fpage" title="fpage">76</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32117996">32117996</a></span></span></li> <li tag="ref"><a name="CIT0139" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">RX</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">Q</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pei</span><span class="given-names" tagx="given-names" title="given-names">XH</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">Effects of Brucine on the OPG/RANKL/RANK Signaling Pathway in MDA-MB-231 and MC3T3-E1 Cell Coculture System</span>. <span class="source" tagx="source" title="source">Evidence-Based Complementary and Alternative Medicine</span><span class="volume" tagx="volume" title="volume">2017</span>:<span class="fpage" tagx="fpage" title="fpage">1</span>â€"<span class="lpage" tagx="lpage" title="lpage">6</span>.</span></li> <li tag="ref"><a name="CIT0140" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xue</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Niu</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2020</span>). <span class="mixed-article-title" title="mixed-article-title">Engineering a biodegradable multifunctional antibacterial bioactive nanosystem for enhancing tumor photothermo-chemotherapy and bone regeneration</span>. <span class="source" tagx="source" title="source">ACS Nano</span><span class="volume" tagx="volume" title="volume">14</span>:<span class="fpage" tagx="fpage" title="fpage">442</span>â€"<span class="lpage" tagx="lpage" title="lpage">53</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31702885">31702885</a></span></span></li> <li tag="ref"><a name="CIT0141" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yan</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gao</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title">A carboxyl-terminated dendrimer enables osteolytic lesion targeting and photothermal ablation of malignant bone tumors</span>. <span class="source" tagx="source" title="source">ACS Appl Mater Interfaces</span><span class="volume" tagx="volume" title="volume">11</span>:<span class="fpage" tagx="fpage" title="fpage">160</span>â€"<span class="lpage" tagx="lpage" title="lpage">68</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30525391">30525391</a></span></span></li> <li tag="ref"><a name="CIT0142" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhu</span><span class="given-names" tagx="given-names" title="given-names">KC</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yuan</span><span class="given-names" tagx="given-names" title="given-names">XW</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2020</span>). <span class="mixed-article-title" title="mixed-article-title">Curcumin has immunomodulatory effects on RANKL-stimulated osteoclastogenesis inÂ vitro and titanium nanoparticle-induced bone loss inÂ vivo</span>. <span class="source" tagx="source" title="source">J Cell Mol Med</span><span class="volume" tagx="volume" title="volume">24</span>:<span class="fpage" tagx="fpage" title="fpage">1553</span>â€"<span class="lpage" tagx="lpage" title="lpage">67</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31845532">31845532</a></span></span></li> <li tag="ref"><a name="CIT0143" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">YX</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hua</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">MK</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Fabrication and characterization of electrospinning/3D printing bone tissue engineering scaffold</span>. <span class="source" tagx="source" title="source">RSC Adv</span><span class="volume" tagx="volume" title="volume">6</span>:<span class="fpage" tagx="fpage" title="fpage">110557</span>â€"<span class="lpage" tagx="lpage" title="lpage">65</span>.</span></li> <li tag="ref"><a name="CIT0144" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yuan</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lian</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">Q</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title">Phosphatidyl inositol 3-kinase (PI3K)-mTOR inhibitor PKI-402 inhibits breast cancer induced osteolysis</span>. <span class="source" tagx="source" title="source">Cancer Lett</span><span class="volume" tagx="volume" title="volume">443</span>:<span class="fpage" tagx="fpage" title="fpage">135</span>â€"<span class="lpage" tagx="lpage" title="lpage">44</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30540926">30540926</a></span></span></li> <li tag="ref"><a name="CIT0145" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zeng</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hoque</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Varghese</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title">Biomaterial-assisted local and systemic delivery of bioactive agents for bone repair</span>. <span class="source" tagx="source" title="source">Acta Biomater</span><span class="volume" tagx="volume" title="volume">93</span>:<span class="fpage" tagx="fpage" title="fpage">152</span>â€"<span class="lpage" tagx="lpage" title="lpage">68</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30711659">30711659</a></span></span></li> <li tag="ref"><a name="CIT0146" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">LB</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tian</span><span class="given-names" tagx="given-names" title="given-names">ZB</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">Inhibitory effect of quercetin on titanium particle induced endoplasmic reticulum stress related apoptosis and inÂ vivo osteolysis</span>. <span class="source" tagx="source" title="source">Bioscience Reports</span><span class="volume" tagx="volume" title="volume">37</span>:<span class="fpage" tagx="fpage" title="fpage">BSR20170961</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28760844">28760844</a></span></span></li> <li tag="ref"><a name="CIT0147" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xiao</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title">Application of hydroxyapatite nanoparticles in tumor-associated bone segmental defect</span>. <span class="source" tagx="source" title="source">Sci Adv</span><span class="volume" tagx="volume" title="volume">5</span>:<span class="fpage" tagx="fpage" title="fpage">eaax6946</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31414050">31414050</a></span></span></li> <li tag="ref"><a name="CIT0148" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">YY</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zou</span><span class="given-names" tagx="given-names" title="given-names">BH</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tan</span><span class="given-names" tagx="given-names" title="given-names">YH</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title">Sinomenine inhibits osteolysis in breast cancer by reducing IL-8/CXCR1 and c-Fos/NFATc1 signaling</span>. <span class="source" tagx="source" title="source">Pharmacol Res</span><span class="volume" tagx="volume" title="volume">142</span>:<span class="fpage" tagx="fpage" title="fpage">140</span>â€"<span class="lpage" tagx="lpage" title="lpage">50</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30797069">30797069</a></span></span></li> <li tag="ref"><a name="CIT0149" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">P-P</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ge</span><span class="given-names" tagx="given-names" title="given-names">Y-W</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">X-L</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2020</span>). <span class="mixed-article-title" title="mixed-article-title">Ordered arrangement of hydrated GdPO4 nanorods in magnetic chitosan matrix promotes tumor photothermal therapy and bone regeneration against breast cancer bone metastases</span>. <span class="source" tagx="source" title="source">Chem Eng J</span><span class="volume" tagx="volume" title="volume">381</span>:<span class="fpage" tagx="fpage" title="fpage">122694</span>.</span></li> <li tag="ref"><a name="CIT0150" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">Y-P</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ye</span><span class="given-names" tagx="given-names" title="given-names">W-L</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">D-Z</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">Redox and pH dual sensitive bone targeting nanoparticles to treat breast cancer bone metastases and inhibit bone resorption</span>. <span class="source" tagx="source" title="source">Nanoscale</span><span class="volume" tagx="volume" title="volume">9</span>:<span class="fpage" tagx="fpage" title="fpage">6264</span>â€"<span class="lpage" tagx="lpage" title="lpage">77</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28470315">28470315</a></span></span></li> <li tag="ref"><a name="CIT0151" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">YQ</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">SP</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">DQ</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">The role of spinal GABAB receptors in cancer-induced bone pain in rats</span>. <span class="source" tagx="source" title="source">J Pain</span><span class="volume" tagx="volume" title="volume">18</span>:<span class="fpage" tagx="fpage" title="fpage">933</span>â€"<span class="lpage" tagx="lpage" title="lpage">46</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28323246">28323246</a></span></span></li> <li tag="ref"><a name="CIT0152" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhu</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">Nonviral cancer gene therapy: delivery cascade and vector nanoproperty integration</span>. <span class="source" tagx="source" title="source">Adv Drug Deliv Rev</span><span class="volume" tagx="volume" title="volume">115</span>:<span class="fpage" tagx="fpage" title="fpage">115</span>â€"<span class="lpage" tagx="lpage" title="lpage">54</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28778715">28778715</a></span></span></li> <li tag="ref"><a name="CIT0153" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhu</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huo</span><span class="given-names" tagx="given-names" title="given-names">Q</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xu</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span> (<span class="year" tagx="year" title="year">2018</span>). <span class="mixed-article-title" title="mixed-article-title">Bortezomib-catechol conjugated prodrug micelles: combining bone targeting and aryl boronate-based pH-responsive drug release for cancer bone-metastasis therapy</span>. <span class="source" tagx="source" title="source">Nanoscale</span><span class="volume" tagx="volume" title="volume">10</span>:<span class="fpage" tagx="fpage" title="fpage">18387</span>â€"<span class="lpage" tagx="lpage" title="lpage">97</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30256367">30256367</a></span></span></li> </ul> </div> </div>  </body></html>